Other otitis externa (chronic)

H8_EXT_OTH

otitis externa: Inflammation of the anatomical structures of the outer ear and ear canal secondary to an infectious process. Bacterial etiology is most common, but fungal infection is also possible. Symptoms include erythema, edema, and pain.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H60.8 Hospital discharge: ICD-9 — 3801 Hospital discharge: excluded ICD-9 — 3801A\|3801B\|3801C Cause of death: ICD-10 — H60.8 Cause of death: ICD-9 — 3801 Cause of death: excluded ICD-9 — 3801A\|3801B\|3801C 2 out of 7 registries used, show all original rules.	2508
4. Check minimum number of events None	2508
5. Include endpoints None	2508
6. Filter based on genotype QC (FinnGen only)	2508

Control definitions (FinnGen only)

Control exclude: H8_EXTERNAL

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H60
Name in latin: Alia otitis externa specificata

NAME	H8_EXT_OTH
CONTROL_EXCLUDE	H8_EXTERNAL
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H608
HD_ICD_9	3801
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL	3801A\|3801B\|3801C
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H608
COD_ICD_9	3801
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL	3801A\|3801B\|3801C
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other otitis externa (chronic) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	17524	9534	7906
Only index persons	16141	8961	7180
Unadjusted period prevalence (%)
Whole population	0.25	0.27	0.22
Only index persons	0.30	0.33	0.27
Median age at first event (years)
Whole population	50.96	50.37	51.78
Only index persons	51.17	50.52	51.97

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2508	1469	1039
Unadjusted period prevalence (%)	0.48	0.50	0.46
Median age at first event (years)	54.84	51.51	59.56

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2248: Matched controls
22479

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H60.8

ICD-10 Finland

Other otitis externa

9968.1

323.0

2214

118

H60.3

ICD-10 Finland

Other infective otitis externa

63.7

323.0

395

H60.9

ICD-10 Finland

Otitis externa, unspecified

22.8

323.0

741

475

UDC00

NOMESCO Finland

Ear microscopy

8.7

218.2

515

742

H60

ICD-10 Finland

Otitis externa

11.0

173.0

349

370

Z01.1

ICD-10 Finland

Examination of ears and hearing

4.6

146.1

587

1592

H70

ICPC

Otitis externa

17.9

144.0

231

143

H01

ICPC

Ear pain/earache

5.1

136.5

490

1171

H66.0

ICD-10 Finland

Acute suppurative otitis media

6.4

131.3

377

686

H61.2

ICD-10 Finland

Impacted cerumen

8.4

127.9

300

406

H29

ICPC

Ear symptom/complaint other

4.9

121.0

443

1069

H66.9

ICD-10 Finland

Otitis media, unspecified

6.1

112.3

330

612

S03CA04

ATC

hydrocortisone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)

10.4

107.9

220

231

S02CA02

ATC

flumetasone and antiinfectives; otic

6.3

103.4

298

536

H04

ICPC

Ear discharge

9.8

101.6

214

238

H60.5

ICD-10 Finland

Acute otitis externa, noninfective

40.0

90.1

114

H60.1

ICD-10 Finland

Cellulitis of external ear

20.6

84.1

127

H72.0

ICD-10 Finland

Central perforation of tympanic membrane

13.5

82.4

147

116

DFF00

NOMESCO Finland

Pure tone audiometry

4.2

81.2

343

927

J01DB01

ATC

cefalexin; oral

3.0

79.5

1953

15516

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

3.1

77.5

495

1862

D07AB02

ATC

hydrocortisone butyrate; topical

2.5

74.9

782

3957

TDA90

NOMESCO Finland

Removal wax from ear

16.3

74.2

122

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

2.8

72.1

560

2379

H66.3

ICD-10 Finland

Other chronic suppurative otitis media

39.3

68.7

H65.3

ICD-10 Finland

Chronic mucoid otitis media

8.6

67.2

151

186

H92.0

ICD-10 Finland

Otalgia

5.1

66.8

225

479

H13

ICPC

Plugged feeling ear

2.7

60.4

498

2162

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

5.4

58.2

185

368

J01MA02

ATC

ciprofloxacin; systemic

2.1

58.1

950

5771

H60.0

ICD-10 Finland

Abscess of external ear

53.9

57.2

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.0

56.1

1240

8489

S03CA01

ATC

dexamethasone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)

7.0

54.1

139

210

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

3.9

53.8

236

649

D07AC01

ATC

betamethasone; topical

2.1

53.2

850

5061

H62.0*A46

ICD-10 Finland

Otitis externa in erysipelas

187.8

53.2

H61.8

ICD-10 Finland

Other specified disorders of external ear

25.6

51.3

J01DA01

ATC

[U] cefalexin; systemic

2.0

50.8

1461

10874

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.8

50.7

381

1552

DBD20

NOMESCO Finland

Plastic repair of external auditory canal

58.4

48.6

H81

ICPC

Excessive ear wax

2.5

48.1

434

1956

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

3.9

47.6

209

574

H66.4

ICD-10 Finland

Suppurative otitis media, unspecified

22.2

47.2

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

2.0

43.5

687

3993

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

5.1

43.0

142

294

H65.0

ICD-10 Finland

Acute serous otitis media

9.1

41.8

103

H72.9

ICD-10 Finland

Perforation of tympanic membrane, unspecified

18.0

40.3

H71

ICD-10 Finland

Cholesteatoma of middle ear

11.9

39.9

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

4.4

38.8

147

351

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.0

38.7

662

3933

N02BE01

ATC

paracetamol; systemic, rectal

2.1

38.6

1899

16237

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

5.7

38.1

113

206

DC1AD

NOMESCO Finland

Temporalbone CT

11.8

38.1

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.2

37.3

464

2417

H90.6

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, bilateral

7.1

37.2

135

E0000UV

ATC

1.8

37.0

917

6193

J01CA04

ATC

amoxicillin; systemic

2.0

36.9

1821

15385

H65.2

ICD-10 Finland

Chronic serous otitis media

11.3

36.7

N02AX02

ATC

tramadol; systemic, rectal

1.8

35.2

935

6423

J01FF01

ATC

clindamycin; systemic

1.9

34.8

637

3851

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

7.3

34.0

117

H60.4

ICD-10 Finland

Cholesteatoma of external ear

172.5

32.8

G47.3

ICD-10 Finland

Sleep apnoea

2.0

32.2

485

2711

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.4

32.0

298

1343

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.1

32.0

425

2257

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

4.9

31.7

107

227

R03AC02

ATC

salbutamol; inhalant

1.7

31.3

1162

8719

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.8

31.2

631

3925

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

31.0

932

6570

R51.80

ICD-10 Finland

Headache

2.2

30.9

364

1835

3801X

ICD-9 Finland

Disorders of external ear, Infective otitis externa[OTITIS EXTERNA CHRONICA NUD]

+∞

30.3

R01AD09

ATC

mometasone; nasal

1.7

30.2

1001

7240

J02AC01

ATC

fluconazole; systemic

1.7

29.8

881

6160

WX110

NOMESCO Finland

Local anesthesy

1.7

29.8

1514

12339

H66

ICD-10 Finland

Suppurative and unspecified otitis media

4.8

29.7

101

216

H61.3

ICD-10 Finland

Acquired stenosis of external ear canal

157.1

29.7

H02AB06

ATC

prednisolone; systemic

1.7

29.0

1019

7464

R01AD08

ATC

fluticasone; nasal

1.8

28.6

648

4161

H65.1

ICD-10 Finland

Other acute nonsuppurative otitis media

7.7

28.6

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

28.4

1544

12724

M25.5

ICD-10 Finland

Pain in joint

1.8

28.3

644

4141

A02BC02

ATC

pantoprazole; systemic

1.6

28.2

1381

11040

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

27.4

914

6564

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

2.2

27.3

318

1587

D07AC13

ATC

mometasone; topical

1.8

27.1

645

4191

A46

ICD-10 Finland

Erysipelas

2.2

27.0

309

1531

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

26.8

784

5416

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

26.8

1052

7883

SPAT1263

SPAT

Sampling

1.6

26.8

934

6777

M54.5

ICD-10 Finland

Low back pain

1.7

26.7

708

4751

R5140

NOMESCO Finland

Monitoring the use of the aid

2.4

26.7

254

1154

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.6

26.5

1196

9283

Z97.4

ICD-10 Finland

Presence of external hearing-aid

3.6

26.4

125

365

DAX08

NOMESCO Finland

Fitting of hearing aid

3.7

26.2

118

330

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.7

26.2

647

4247

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.8

26.2

520

3184

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.4

26.1

242

1084

S02CA06

ATC

dexamethasone and antiinfectives; otic

9.3

26.0

H02

ICPC

Hearing complaint

2.2

25.8

275

1317

H04.10

ICD-10 Finland

Dry eye syndrome

2.4

25.5

239

1076

H70.1

ICD-10 Finland

Chronic mastoiditis

28.7

25.4

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

25.3

956

7048

D07XC01

ATC

betamethasone, combinations; topical

2.2

25.0

287

1420

J01FA10

ATC

azithromycin; systemic

1.6

25.0

1270

10093

H90.1

ICD-10 Finland

Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side

6.6

24.7

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

24.5

481

2925

R42

ICD-10 Finland

Dizziness and giddiness

1.8

24.0

461

2782

D07CC01

ATC

betamethasone and antibiotics; topical

2.1

23.8

312

1635

SPAT1043

SPAT

Audiometry

2.3

23.8

243

1141

H74.1

ICD-10 Finland

Adhesive middle ear disease

23.9

23.5

DCD00

NOMESCO Finland

Myringoplasty

11.8

23.5

N03AX16

ATC

pregabalin; oral

1.7

22.8

519

3299

DBB00

NOMESCO Finland

Excision of lesion of external auditory canal

232.2

22.7

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

22.4

979

7415

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.7

22.2

523

3357

EBA00

NOMESCO Finland

Extraction of tooth

1.6

21.9

717

5041

R74

ICPC

Upper respiratory infection acute

1.7

21.9

621

4199

R06AE07

ATC

cetirizine; oral

1.6

21.8

937

7050

J20

ICD-10 Finland

Acute bronchitis

2.2

21.7

229

1089

D07CA01

ATC

hydrocortisone and antibiotics; topical

2.0

21.7

298

1586

Z3229

NOMESCO Finland

Other healthcare associate professional

2.4

21.7

201

899

G44.2

ICD-10 Finland

Tension-type headache

2.0

21.4

304

1639

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

21.2

570

3792

H66.1

ICD-10 Finland

Chronic tubotympanic suppurative otitis media

14.8

21.2

SPAT1310

SPAT

Counselling related to known health issue

1.6

21.0

688

4826

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.5

20.9

168

696

L17

ICPC

Foot/toe symptom/complaint

1.7

20.8

535

3512

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.6

20.7

703

4975

N06AB04

ATC

citalopram; systemic

1.7

20.6

461

2905

SPAT1312

SPAT

General health counselling

1.6

20.4

697

4936

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.8

20.3

414

2531

E66.01

ICD-10 Finland

Obesity due to excess calories

2.4

20.2

186

826

P01AB01

ATC

metronidazole; oral, rectal

1.6

20.2

824

6089

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.5

19.9

167

707

M79.6

ICD-10 Finland

Pain in limb

1.6

19.7

735

5309

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.7

19.6

469

3008

J01AA02

ATC

doxycycline; systemic

1.6

19.5

1643

14269

XQ800

NOMESCO Finland

Prick test

2.3

19.5

191

875

K03.66

ICD-10 Finland

Tooth plaque

2.5

19.4

162

686

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

19.4

483

3133

J01FA06

ATC

roxithromycin; oral

1.5

19.2

837

6261

J01DA06

ATC

[U] cefuroxime; systemic

1.9

19.1

326

1876

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.1

18.8

224

1120

XQ802

NOMESCO Finland

Epicutan test

2.9

18.8

115

406

H73.1

ICD-10 Finland

Chronic myringitis

70.5

18.7

M79.1

ICD-10 Finland

Myalgia

1.9

18.6

286

1587

S29

ICPC

Skin symptom/complaint other

1.8

18.6

368

2225

DFF15

NOMESCO Finland

Speech audiometry

3.0

18.4

110

380

SGA01

NOMESCO Finland

Tooth opening as first aid

1.8

18.3

345

2051

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

18.2

359

2166

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.9

18.1

275

1518

UJF32

NOMESCO Finland

Coloscopy

1.6

18.0

521

3512

J01FA09

ATC

clarithromycin; systemic

1.6

17.9

672

4836

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.1

17.8

219

1111

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

17.6

374

2306

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.8

17.6

115

421

WX290

NOMESCO Finland

Other blockade of nerve

1.5

17.6

930

7221

L15

ICPC

Knee symptom/complaint

1.7

17.6

436

2815

UKC02

NOMESCO Finland

Cystoscopy

1.8

17.5

326

1926

E000001

ATC

1.7

17.5

442

2870

H72.2

ICD-10 Finland

Other marginal perforations of tympanic membrane

15.7

17.5

D07BA04

ATC

hydrocortisone and antiseptics; topical

2.1

17.4

218

1116

A02BC05

ATC

esomeprazole; systemic

1.5

17.4

823

6236

L03

ICPC

Low back symptom/complaint

1.6

17.1

492

3305

M75

ICD-10 Finland

Shoulder lesions

2.8

17.1

109

396

A10BA02

ATC

metformin; oral

1.6

17.0

538

3705

H10

ICD-10 Finland

Conjunctivitis

2.4

16.9

151

660

SPAT1301

SPAT

No procedures

1.5

16.9

650

4690

R06AX27

ATC

desloratadine; oral

1.6

16.9

556

3867

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

16.8

794

6004

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.5

16.7

653

4728

H90.4

ICD-10 Finland

Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

2.9

16.7

101

353

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.5

16.6

1177

9667

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

16.6

770

5791

DEB10

NOMESCO Finland

Attico-antro-mastoidectomy

171.2

16.5

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.7

16.5

433

2835

K02.1

ICD-10 Finland

Caries of dentine

1.5

16.3

1183

9745

J01MA12

ATC

levofloxacin; systemic

1.7

16.2

380

2406

S18

ICPC

Laceration/cut

1.5

16.2

838

6442

H02AB04

ATC

methylprednisolone; systemic

1.8

16.0

311

1862

D07AA02

ATC

hydrocortisone; topical

1.8

16.0

296

1745

N05AH04

ATC

quetiapine; oral

1.7

15.9

335

2056

UJF30

NOMESCO Finland

Ileoscopy through colon

2.0

15.8

214

1129

N06AA09

ATC

amitriptyline; systemic

2.0

15.7

218

1161

Z01.2

ICD-10 Finland

Dental examination

1.5

15.7

866

6735

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.7

15.6

112

436

D07AD01

ATC

clobetasol; topical

1.7

15.5

325

1989

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

15.5

506

3499

D05AX52

ATC

calcipotriol, combinations; topical

2.4

15.5

134

579

H93.1

ICD-10 Finland

Tinnitus

2.3

15.5

147

664

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.1

15.4

174

852

DEB20

NOMESCO Finland

Attico-antro-mastoidectomy and tympanotomy

38.3

15.4

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

15.3

1439

12399

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

2.0

15.2

208

1099

WZA90

NOMESCO Finland

Other doctors statement

1.6

15.2

481

3298

WX002

NOMESCO Finland

Sedation and analgesia

1.7

15.2

391

2541

H62.0

ICD-10 Finland

Otitis externa in bacterial diseases classified elsewhere

28.8

15.2

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

15.2

1080

8813

H68.1

ICD-10 Finland

Obstruction of Eustachian tube

5.4

15.1

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.6

15.1

531

3736

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.4

15.0

1097

8988

SPAT1360

SPAT

Extensive global examination

2.1

14.9

165

801

SPAT1260

SPAT

Consultation of another employee

1.7

14.8

365

2345

M03BX02

ATC

tizanidine; oral

1.4

14.8

1253

10546

H72.8

ICD-10 Finland

Other perforations of tympanic membrane

16.6

14.8

E000006

ATC

2.2

14.7

161

776

M01AB05

ATC

diclofenac; systemic, rectal

1.4

14.6

1353

11567

38110

ICD-8 Finland

Otitis media without mention of mastoiditis, Chronic

6.3

14.6

N03AX12

ATC

gabapentin; oral

1.7

14.5

308

1891

XF640

NOMESCO Finland

3.3

14.5

226

R06.0

ICD-10 Finland

Dyspnoea

1.6

14.5

480

3329

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.8

14.4

276

1642

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

14.4

462

3176

SPAT1153

SPAT

Removal of sutures

1.5

14.3

618

4549

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

14.2

361

2335

N06AX11

ATC

mirtazapine; oral

1.5

14.2

621

4580

L01

ICPC

Neck symptom/complaint

1.7

14.1

290

1765

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.4

14.1

797

6193

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

14.0

227

1280

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

14.0

421

2848

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

14.0

742

5692

L08

ICPC

Shoulder symptom/complaint

1.6

14.0

382

2521

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

13.9

603

4435

R53

ICD-10 Finland

Malaise and fatigue

1.6

13.9

397

2651

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

13.7

512

3639

R5120

NOMESCO Finland

Preparation of an aid

3.5

13.7

188

N05BA04

ATC

oxazepam; oral

1.5

13.6

483

3393

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.7

13.5

289

1775

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.9

13.4

190

1020

Z96.2

ICD-10 Finland

Presence of otological and audiological implants

21.3

13.3

AA1AD

NOMESCO Finland

CT of head and brain

1.6

13.3

440

3041

E66.00

ICD-10 Finland

Metabolic syndrome

2.3

13.3

120

532

H65.9

ICD-10 Finland

Nonsuppurative otitis media, unspecified

6.7

13.3

T16

ICD-10 Finland

Foreign body in ear

6.7

13.3

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.5

13.3

517

3708

A02BC03

ATC

lansoprazole; oral

1.5

13.2

562

4107

N06AB03

ATC

fluoxetine; oral

1.7

13.2

265

1599

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

13.1

403

2735

H65.4

ICD-10 Finland

Other chronic nonsuppurative otitis media

12.2

13.1

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.4

13.1

110

470

S02AA03

ATC

boric acid; otic

6.3

13.0

D07AB08

ATC

desonide; topical

1.8

13.0

222

1269

D01AC02

ATC

miconazole; topical

2.0

12.9

162

829

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.2

12.9

130

605

H92.1

ICD-10 Finland

Otorrhoea

19.1

12.9

M54

ICD-10 Finland

Dorsalgia

1.8

12.9

228

1322

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.4

12.8

112

488

C03CA01

ATC

furosemide; systemic

1.5

12.8

486

3463

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

3.7

12.7

147

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

12.7

552

4047

L12

ICPC

Hand/finger symptom/complaint

1.7

12.7

291

1828

M54.2

ICD-10 Finland

Cervicalgia

2.1

12.7

151

756

L28

ICPC

Limited function/disability (L)

1.7

12.6

290

1823

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

12.5

790

6227

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

4.2

12.5

115

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

12.4

363

2427

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

12.4

458

3240

K10.3

ICD-10 Finland

Alveolitis of jaws

2.4

12.3

102

432

A07AA02

ATC

nystatin; oral

2.2

12.2

125

585

H02AB07

ATC

prednisone; oral

1.7

12.2

283

1779

E66.8

ICD-10 Finland

Other obesity

2.3

12.2

117

531

L16

ICPC

Ankle symptom/complaint

1.8

12.0

203

1156

DEB30

NOMESCO Finland

Radical mastoidectomy

18.1

12.0

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

12.0

857

6892

T82

ICPC

Obesity

2.6

11.9

337

M01AE02

ATC

naproxen; oral, rectal

1.4

11.9

1158

9813

N06AB10

ATC

escitalopram; oral

1.6

11.9

386

2647

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

4.9

11.9

ZXA00

NOMESCO Finland

Right side

1.5

11.9

493

3573

J01DC02

ATC

cefuroxime; systemic

2.1

11.9

132

642

R06.5

ICD-10 Finland

Mouth breathing

1.9

11.9

168

901

D07BC01

ATC

betamethasone and antiseptics; topical

1.7

11.9

243

1476

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

5.0

11.9

D02AE01

ATC

carbamide; topical

2.0

11.8

150

772

R02

ICPC

Shortness of breath/dyspnoea

1.7

11.8

241

1460

SPAT1211

SPAT

Application of soft bandage

1.9

11.8

187

1045

P29

ICPC

Psychological sympt/compl other

2.2

11.8

125

597

WX722

NOMESCO Finland

PEEP

2.3

11.7

104

458

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.5

11.7

488

3545

N03AX09

ATC

lamotrigine; oral

2.3

11.7

104

459

T90

ICPC

Diabetes non-insulin dependent

1.5

11.5

420

2961

DFF30

NOMESCO Finland

Loudness discomfort Level (LDL)

3.1

11.5

204

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.4

11.5

715

5603

M01AE01

ATC

ibuprofen; systemic, rectal

1.5

11.5

1895

17569

H62.2*B36.9

ICD-10 Finland

Otomycosis NOS

+∞

11.5

SDA02

NOMESCO Finland

Parodonthologic therapy

1.4

11.5

640

4917

N06AB06

ATC

sertraline; oral

1.8

11.4

219

1303

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

11.4

1329

11564

L20.0

ICD-10 Finland

Besnier prurigo

2.1

11.4

135

674

S10

ICPC

Boil/carbuncle

2.2

11.4

117

552

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.0

11.4

148

770

R01AD12

ATC

fluticasone furoate; nasal

1.4

11.3

576

4345

H27

ICPC

Fear of ear disease

4.5

11.3

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.9

11.3

160

860

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

11.3

316

2092

A02BC01

ATC

omeprazole; systemic

1.5

11.2

527

3913

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.9

11.2

163

885

H60.2

ICD-10 Finland

Malignant otitis externa

25.1

11.1

S76

ICPC

Skin infection other

2.3

11.1

105

475

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

11.0

417

2957

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.3

11.0

419

N05CD07

ATC

temazepam; oral

1.7

11.0

223

1349

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

10.9

321

2145

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.8

10.9

181

1027

R52.2

ICD-10 Finland

Other chronic pain

2.7

10.9

276

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.9

10.8

150

800

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.0

10.8

137

704

D23.2

ICD-10 Finland

Benign neoplasm: Skin of ear and external auricular canal

5.1

10.8

38700

ICD-8 Finland

Other disease of ear and mastoid process, Cholesteatoma of ear

17.9

10.7

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

10.6

461

3361

N07CA01

ATC

betahistine; oral

1.9

10.6

151

813

K05.31

ICD-10 Finland

Periodontitis pronounced

1.8

10.6

186

1076

4122

FHL

Tympanostomy (tympanic tube)

4.1

10.6

R03BB04

ATC

tiotropium bromide; inhalant

1.8

10.6

191

1115

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

10.6

261

1671

D82

ICPC

Teeth/gum disease

1.4

10.6

692

5457

N01

ICPC

Headache

1.7

10.6

216

1309

Z3231

NOMESCO Finland

Registered nurse

1.4

10.5

522

3912

J01DB05

ATC

cefadroxil; oral

2.3

10.5

440

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.8

10.5

174

988

D07XB02

ATC

triamcinolone, combinations; topical

4.4

10.5

3821A

ICD-9 Finland

Suppurative and unspecified otitis media, Chronic tubotympanic suppurative otitis media

14.3

10.5

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

10.5

464

3402

3801A

ICD-9 Finland

Disorders of external ear, Infective otitis externa[OTITIS EXTERNA ACUTA DIFFUSA]

+∞

10.4

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.6

10.4

259

1662

A10AE04

ATC

insulin glargine; parenteral

1.8

10.4

180

1037

M01AH05

ATC

etoricoxib; oral

1.3

10.4

1153

9890

S04

ICPC

Lump/swelling localized

1.8

10.3

180

1039

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

10.3

537

4056

R05

ICPC

Cough

1.5

10.3

435

3155

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

1.5

10.3

457

3348

F60.9

ICD-10 Finland

Personality disorder, unspecified

4.1

10.3

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

10.3

496

3696

R05

ICD-10 Finland

Cough

1.5

10.2

372

2614

ZXA10

NOMESCO Finland

Bilateral

1.5

10.2

354

2460

H90.7

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

4.3

10.2

R21

ICPC

Throat symptom/complaint

1.5

10.2

395

2816

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.6

10.2

260

1680

ZXA05

NOMESCO Finland

Left side

1.5

10.2

455

3341

DEB25

NOMESCO Finland

Attico-antro-mastoidectomy and tympanoplasty

13.2

10.2

R07.3

ICD-10 Finland

Other chest pain

1.8

10.1

174

1001

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.1

10.0

112

549

DGW00

NOMESCO Finland

Dilatation of eustachian tube

14.6

10.0

M70.6

ICD-10 Finland

Trochanteric bursitis

1.7

10.0

215

1323

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

9.9

480

3576

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.8

9.9

167

956

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.2

9.9

429

H51

ICPC

Ear, I&d/flush/aspiration

4.1

9.8

R03BA01

ATC

beclometasone; inhalant

1.6

9.8

265

1732

H72

ICD-10 Finland

Perforation of tympanic membrane

26.1

9.8

F32

ICD-10 Finland

Depressive episode

2.1

9.8

104

499

N06AX16

ATC

venlafaxine; oral

1.6

9.8

268

1759

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

9.8

306

2075

TDA10

NOMESCO Finland

Needle biopsy of auricle or external auditory canal

10.7

9.8

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.8

9.7

162

924

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.7

9.7

186

1109

J01DA08

ATC

[U] cefaclor; oral

1.7

9.6

225

1418

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

9.6

381

2724

K59.0

ICD-10 Finland

Constipation

2.1

9.6

105

512

Z94.0

ICD-10 Finland

Kidney transplant status

4.6

9.6

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

9.6

309

2113

H71

ICPC

Acute otitis media/myringitis

4.4

9.5

R11

ICD-10 Finland

Nausea and vomiting

1.8

9.5

151

846

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

9.5

203

1248

A04

ICPC

Weakness/tiredness general

1.6

9.5

247

1603

R03BA02

ATC

budesonide; inhalant

1.5

9.4

337

2354

J31.0

ICD-10 Finland

Chronic rhinitis

1.8

9.4

156

887

DEE00

NOMESCO Finland

Osseous fixation of hearing aid

100.4

9.4

A10BJ02

ATC

liraglutide; parenteral

3.0

9.4

176

A06AD11

ATC

lactulose; oral

1.6

9.4

247

1605

H91.9

ICD-10 Finland

Hearing loss, unspecified

2.3

9.4

377

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

5.1

9.4

H62.2*B44.8

ICD-10 Finland

Otitis externa in aspergillosis

+∞

9.4

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

9.4

150

843

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

9.3

786

6427

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.7

9.3

188

1134

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.8

9.3

162

933

R13

ICD-10 Finland

Dysphagia

2.0

9.3

122

636

J02AC02

ATC

itraconazole; systemic

1.5

9.3

346

2442

A01

ICPC

Pain general/multiple sites

1.9

9.2

143

794

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.8

9.2

170

999

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

4.0

9.2

N05CF01

ATC

zopiclone; oral

1.4

9.2

585

4569

SBB10

NOMESCO Finland

Teeth copy

1.9

9.2

137

750

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.8

9.1

169

996

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.7

9.1

210

1317

EBA10

NOMESCO Finland

Surgical removal of tooth

1.6

9.1

230

1479

F45.8

ICD-10 Finland

Other somatoform disorders

1.9

9.0

133

726

K07.60

ICD-10 Finland

Snapping jaw

2.1

9.0

102

503

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.1

8.9

443

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.3

8.9

367

H01.0

ICD-10 Finland

Blepharitis

2.0

8.8

110

564

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

8.8

373

2701

J01FA01

ATC

erythromycin; systemic

1.5

8.8

275

1861

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

8.8

156

906

A02BA02

ATC

ranitidine; systemic

1.5

8.8

354

2535

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

8.8

383

2787

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.8

8.8

152

875

XF402

NOMESCO Finland

ECG with work load test

1.6

8.8

207

1308

K08.80

ICD-10 Finland

Toothache NOS

1.8

8.8

157

913

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

8.7

565

4424

SPAT1254

SPAT

Administration of medicine

1.5

8.6

267

1804

SPAT1234

SPAT

Support of social functional capacity

2.2

8.6

403

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

8.6

277

1892

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

8.6

255

1708

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.4

8.6

115

R03BA05

ATC

fluticasone; inhalant

1.5

8.6

351

2524

N03AG01

ATC

valproic acid; systemic, rectal

1.9

8.5

120

644

SPAT1283

SPAT

Restricted health certificate

1.5

8.5

333

2368

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.3

8.5

344

A02BA04

ATC

nizatidine; systemic

1.8

8.5

139

789

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

8.5

236

1554

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

8.5

363

2631

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

8.5

168

1010

H90.0

ICD-10 Finland

Conductive hearing loss, bilateral

5.4

8.4

K30

ICD-10 Finland

Functional dyspepsia

1.6

8.4

196

1235

DEB00

NOMESCO Finland

Cortical mastoidectomy

90.4

8.4

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.6

8.4

200

1264

N05AH03

ATC

olanzapine; systemic

1.9

8.4

111

584

E66.9

ICD-10 Finland

Obesity, unspecified

2.3

8.4

319

D05AX02

ATC

calcipotriol; topical

2.2

8.4

406

S06.0

ICD-10 Finland

Concussion

1.6

8.3

195

1230

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.6

8.3

249

1670

J45

ICD-10 Finland

Asthma

1.7

8.3

177

1089

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.9

8.3

110

579

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.4

8.3

384

2828

R52.9

ICD-10 Finland

Pain, unspecified

1.7

8.3

153

903

J01MA14

ATC

moxifloxacin; systemic

1.7

8.2

159

950

H25.8

ICD-10 Finland

Other senile cataract

1.7

8.2

172

1051

N05CF02

ATC

zolpidem; oral

1.5

8.2

319

2269

L13

ICPC

Hip symptom/complaint

1.5

8.1

275

1900

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.8

8.1

137

787

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prothetic work

2.1

8.1

423

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.6

8.1

219

38210

ICD-8 Finland

Chronic otitis media with mastoiditis

8.9

8.0

L02

ICPC

Back symptom/complaint

1.7

8.0

169

1035

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

8.0

424

3197

J34.2

ICD-10 Finland

Deviated nasal septum

2.0

8.0

100

516

M02AA10

ATC

ketoprofen; topical

1.5

8.0

277

1922

N05BA01

ATC

diazepam; systemic, rectal

1.5

8.0

241

1620

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

2.3

8.0

316

6146A

ICD-9 Finland

Inflammatory disease of ovary, Fallopian tube, pelvic cellular tissue and peritoneum, Pelvic peritoneal adhesions, female

4.1

8.0

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.6

7.9

208

1352

K04.08

ICD-10 Finland

Other specified pulpit

1.8

7.9

123

685

F29

ICPC

Eye symptom/complaint other

1.7

7.9

153

911

N07BA03

ATC

varenicline; oral

2.0

7.9

510

L04AA06

ATC

mycophenolic acid; systemic

3.1

7.9

134

L40

ICD-10 Finland

Psoriasis

3.0

7.9

140

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

7.9

354

2587

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.8

7.9

135

776

SPAT1172

SPAT

Guidance concerning hydration

3.1

7.8

135

SPF30

NOMESCO Finland

Soling for prothesis

3.2

7.8

124

Z3226

NOMESCO Finland

Physiotherapist

1.4

7.8

340

2469

R06AX22

ATC

ebastine; oral

1.5

7.8

320

2301

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

7.8

517

4050

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.9

7.8

110

592

N06AX21

ATC

duloxetine; oral

1.6

7.8

197

1268

137

Kela drug reimbursment

Uraemia requiring dialysis

4.8

7.8

J37.0

ICD-10 Finland

Chronic laryngitis

2.3

7.7

295

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.0

7.7

142

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.6

7.7

204

1329

ZXD20

NOMESCO Finland

Day surgery

1.5

7.7

235

1582

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.9

7.7

105

558

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

7.7

172

1072

K04.0

ICD-10 Finland

Pulpitis

1.6

7.7

180

1137

H91.1

ICD-10 Finland

Presbycusis

2.0

7.7

451

A10BB12

ATC

glimepiride; oral

1.8

7.6

117

651

SPAT1240

SPAT

Therapeutic discussion

1.6

7.6

192

1235

H61.9

ICD-10 Finland

Disorder of external ear, unspecified

18.4

7.6

H95.0

ICD-10 Finland

Recurrent cholesteatoma of postmastoidectomy cavity

18.4

7.6

A10BJ06

ATC

semaglutide; parenteral

2.3

7.6

282

N05BE01

ATC

buspirone; oral

2.5

7.6

234

C05AA08

ATC

fluocortolone; rectal, topical

1.5

7.6

251

1726

N06AA12

ATC

doxepin; systemic

2.0

7.6

483

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.6

7.5

196

1271

C10AA01

ATC

simvastatin; oral

1.3

7.5

744

6181

DCD10

NOMESCO Finland

Tympanoplasty

8.9

7.5

X58

ICD-10 Finland

Exposure to other specified factors

1.5

7.5

249

1710

R04.0

ICD-10 Finland

Epistaxis

1.8

7.5

127

729

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.9

7.5

106

573

SGA03

NOMESCO Finland

Demanding opening and dilatation of root canal of tooth

1.6

7.5

172

1080

K05.18

ICD-10 Finland

Chronic gingivitis

1.9

7.5

100

530

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.6

7.5

178

1129

K59.09

ICD-10 Finland

Constipation, unspecified

1.9

7.5

111

609

N17

ICPC

Vertigo/dizziness

1.6

7.4

192

1245

H53.1

ICD-10 Finland

Subjective visual disturbances

1.8

7.4

115

642

Q16.1

ICD-10 Finland

Congenital absence, atresia and stricture of auditory canal (external)

80.3

7.4

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

7.4

217

1446

C09CA01

ATC

losartan; oral

1.4

7.4

409

3104

DE2CG

NOMESCO Finland

Acoustic channel extensive MRI examination with high intensity magnet

3.4

7.4

D73

ICPC

Gastroenteritis presumed infection

2.3

7.4

281

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

7.4

585

4705

DE2BG

NOMESCO Finland

Acoustic channel MRI examination with high intensity magnet

4.1

7.4

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.5

7.4

268

1877

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.8

7.3

165

H03AA01

ATC

levothyroxine sodium; systemic

1.4

7.3

427

3271

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.8

7.3

123

702

F01

ICPC

Eye pain

2.4

7.3

244

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.0

7.3

462

K59.1

ICD-10 Finland

Functional diarrhoea

1.9

7.3

505

D07XB05

ATC

dexamethasone, combinations; topical

2.5

7.3

208

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

2.5

7.3

219

SPAT1262

SPAT

Handing over of treatment supplies

1.4

7.3

317

2306

K11.2

ICD-10 Finland

Sialoadenitis

2.3

7.3

277

S17

ICPC

Abrasion/scratch/blister

2.6

7.2

202

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.5

7.2

224

1516

Z2446

NOMESCO Finland

Social worker

1.8

7.2

124

714

SXB00

NOMESCO Finland

Removeal of sutres from oral mucosa

1.8

7.2

122

698

A10BH01

ATC

sitagliptin; oral

1.7

7.2

155

957

D01

ICPC

Abdominal pain/cramps general

1.6

7.2

197

1294

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.5

7.2

203

3812A

ICD-9 Finland

Nonsuppurative otitis media and Eustachian tube disorders, Chronic mucoid otitis media

3.4

7.2

J01EA01

ATC

trimethoprim; systemic

1.4

7.2

458

3557

H69.0

ICD-10 Finland

Patulous Eustachian tube

7.3

7.2

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

2.3

7.2

280

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.7

7.2

139

831

H25.0

ICD-10 Finland

Senile incipient cataract

1.9

7.2

516

H61.0

ICD-10 Finland

Perichondritis of external ear

20.1

7.1

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.7

7.1

152

934

SFC92

NOMESCO Finland

Other demanding adjuvant procedure of filling therapy

1.8

7.1

123

710

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.9

7.1

519

205

Kela drug reimbursment

Chronic hypertension

1.4

7.1

459

3576

N30.0

ICD-10 Finland

Acute cystitis

1.5

7.1

245

1698

J45.1

ICD-10 Finland

Nonallergic asthma

1.7

7.1

128

750

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.7

7.1

174

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.7

7.1

145

882

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.2

7.0

308

A10AE05

ATC

insulin detemir; parenteral

1.9

7.0

100

542

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.7

7.0

143

870

XKD00

NOMESCO Finland

Uroflowmetry

1.5

7.0

261

1839

L04AA01

ATC

[U] ciclosporin; systemic

3.2

7.0

107

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.6

7.0

156

972

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.6

7.0

178

1148

F03

ICPC

Eye discharge

1.8

7.0

115

655

I78.1

ICD-10 Finland

Naevus, non-neoplastic

2.5

7.0

219

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

7.0

199

1318

A12AA04

ATC

calcium carbonate; oral

3.3

7.0

102

Z71.8

ICD-10 Finland

Other specified counselling

1.4

7.0

425

3280

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

2.1

6.9

337

N05AA02

ATC

levomepromazine; systemic

2.1

6.9

386

SPAT1229

SPAT

Assessment of need for aid

1.7

6.9

130

771

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.7

6.9

128

755

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

6.9

227

1555

TDC10

NOMESCO Finland

Removal of ventilating tube from tympanic membrane

13.8

6.9

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.2

6.9

293

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.8

6.9

148

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

4.4

6.8

H36.00

ICD-10 Finland

Diabetic background retinopathy

3.4

6.8

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.8

6.8

106

593

J01CF05

ATC

flucloxacillin; systemic

2.1

6.8

342

SPAT1044

SPAT

Tympanometry

2.7

6.8

166

NG2AA

NOMESCO Finland

Patella X-ray examination

2.4

6.8

228

A97

ICPC

No disease

1.5

6.8

266

1894

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.9

6.8

492

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.8

6.7

144

N05BB01

ATC

hydroxyzine; systemic

1.8

6.7

116

669

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.7

6.7

123

722

S09

ICPC

Infected finger/toe

2.2

6.7

280

L04AD01

ATC

ciclosporin; systemic

2.7

6.7

161

H66.2

ICD-10 Finland

Chronic atticoantral suppurative otitis media

22.6

6.7

DEA10

NOMESCO Finland

Attico-antrotomy

22.6

6.7

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

6.7

445

3480

SPAT1216

SPAT

Assessment of functional ability

1.5

6.6

248

1750

J33.0

ICD-10 Finland

Polyp of nasal cavity

2.3

6.6

233

RK320

NOMESCO Finland

4.2

6.6

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

6.6

221

1523

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

2.1

6.6

346

L60.0

ICD-10 Finland

Ingrowing nail

2.0

6.6

410

A03

ICPC

Fever

1.4

6.6

301

2208

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.7

6.6

130

783

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

6.5

247

1746

H65

ICD-10 Finland

Nonsuppurative otitis media

4.3

6.5

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.1

6.5

313

R05FB02

ATC

cough suppressants and expectorants

1.3

6.5

679

5656

SBA00

NOMESCO Finland

Microbiological examinations

2.5

6.5

190

C07AB07

ATC

bisoprolol; oral

1.3

6.5

819

6990

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.2

6.5

301

R51

ICD-10 Finland

Headache

1.8

6.5

101

564

H3600, E113

ICD-10 Finland

3.6

6.5

L21.0

ICD-10 Finland

Seborrhoea capitis

4.0

6.5

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

6.5

344

2593

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

1.9

6.5

457

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.3

6.5

229

127

Kela drug reimbursment

Transplant complication

3.0

6.5

114

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.8

6.5

110

632

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

6.5

157

1003

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.7

6.4

129

783

PA7BD

NOMESCO Finland

CT angiography of neck and brain

2.9

6.4

130

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

6.4

184

1226

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.5

6.4

194

1307

N40

ICD-10 Finland

Hyperplasia of prostate

1.4

6.4

317

2361

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.5

6.4

185

1235

R06AE09

ATC

levocetirizine; oral

1.4

6.4

269

1942

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

6.3

298

2194

R03AC03

ATC

terbutaline; inhalant

1.5

6.3

250

1783

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

4.4

6.3

SPAT1311

SPAT

Counselling and guidance related to occupational health

2.2

6.3

289

A10BK03

ATC

empagliflozin; oral

1.7

6.3

116

684

SHA04

NOMESCO Finland

Correction of physiology of bite - very demanding therapy visit

3.4

6.3

R31

ICD-10 Finland

Unspecified haematuria

1.6

6.3

163

1055

R03DC03

ATC

montelukast; oral

1.4

6.3

291

2136

SCA03

NOMESCO Finland

Preventive oral health care, extensive

1.9

6.3

474

XCK10

NOMESCO Finland

Photography of fundus of eye

1.6

6.3

169

1106

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.9

6.3

431

R55

ICD-10 Finland

Syncope and collapse

1.6

6.3

178

1181

3801D

ICD-9 Finland

Disorders of external ear, Infective otitis externa[OTITIS EXTERNA CHRONICA SUPPURATIVA]

+∞

6.3

DEB35

NOMESCO Finland

Radical mastoidectomy with tympanoplasty

+∞

6.3

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.9

6.2

464

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.1

6.2

307

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.8

6.2

101

575

L04AX01

ATC

azathioprine; systemic

2.0

6.2

411

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.7

6.2

125

760

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.4

6.2

245

1749

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.6

6.1

160

1041

P03

ICPC

Feeling depressed

1.6

6.1

166

1090

M15

ICD-10 Finland

Polyarthrosis

1.9

6.1

429

Z04

ICD-10 Finland

Examination and observation for other reasons

3.0

6.1

108

C07AG02

ATC

carvedilol; oral

1.8

6.1

558

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

6.1

127

779

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.5

6.0

171

1135

M77.1

ICD-10 Finland

Lateral epicondylitis

1.7

6.0

124

759

K04.00

ICD-10 Finland

Hyperemia of pulp

1.9

6.0

410

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

6.0

135

844

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.0

6.0

355

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.7

6.0

130

805

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.9

6.0

397

N03AE01

ATC

clonazepam; systemic

1.8

6.0

101

582

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.6

6.0

152

980

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3007853) Bacteria identified in Skin by Aerobe culture

801

2318

4.61

255.46

2.4

1.7

—

(3000494) Fungus identified in Specimen by Culture

606

2328

3.11

116.47

1.9

1.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

539

2414

2.57

74.03

5.2

4.3

31.5

32.3

0.63

276

1677

(3019225) pH of Specimen

451

1958

2.59

65.38

4.5

4.2

—

(3013707) Erythrocyte sedimentation rate by Westergren method

1905

15163

2.07

51.55

4.8

4.0

mm/h

12.7

11.9

1.52

1680

14046

(42870588) Differential panel, method unspecified - Blood

1050

6938

1.88

49.67

6.7

5.9

—

(3042936) Bacteria identified in Isolate by Culture

541

2870

2.13

47.93

2.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

465

2381

2.17

44.84

5.4

6.8

—

(3022096) Basophils/100 leukocytes in Blood

1293

9378

1.78

42.98

7.2

6.0

0.7

0.05

1152

8792

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1145

8035

1.78

42.45

2.3

2.0

pmol/l

96.5

95.4

0.32

554

4256

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1243

8974

1.76

41.42

6.6

6.1

mmol/l

1.2

4.09

1034

8150

(3006504) Eosinophils/100 leukocytes in Blood

1316

9664

1.76

41.26

7.1

6.0

2.9

2.8

1.02

1178

9038

(3013512) EKG study

869

5677

1.81

40.57

4.9

3.7

—

(3019069) Monocytes/100 leukocytes in Blood

1317

9716

1.75

40.23

7.5

6.3

8.5

8.6

0.39

1180

9139

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1330

9911

1.73

38.54

7.6

6.8

mmol/l

1.2

3.15

1109

8400

(3018010) Neutrophils/100 leukocytes in Blood

1324

9863

1.73

38.33

6.9

5.8

57.2

56.9

0.35

1190

9271

(3013115) Eosinophils [#/volume] in Blood

1404

10661

1.72

37.62

7.0

6.1

e9/l

0.2

2.56

1191

9413

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

208

806

2.72

36.98

4.0

mmol/l

25.0

24.8

0.40

188

759

(3022313) Gas panel - Capillary blood

230

942

2.59

36.60

4.0

3.7

—

(3002030) Lymphocytes/100 leukocytes in Blood

1331

10008

1.70

36.54

7.4

6.0

27.9

28.3

0.62

1189

9380

(3037467) Urinalysis macro (dipstick) panel - Urine

1741

14125

1.76

35.85

5.5

4.2

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1886

15670

1.82

35.70

8.3

7.4

u/l

79.9

77.9

0.66

1749

14778

(3009343) pH of Capillary blood

272

1282

2.26

31.56

4.1

3.7

7.4

0.18

150

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

274

1297

2.25

31.46

4.1

3.7

kpa

5.2

0.17

248

1204

(3006315) Basophils [#/volume] in Blood

1336

10297

1.64

31.35

6.8

5.8

e9/l

0.0

0.52

1140

8955

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

263

1230

2.27

31.07

4.0

3.7

mmol/l

1.7

1.8

0.16

200

911

(3021960) Folate [Moles/volume] in Serum or Plasma

695

4541

1.73

30.74

1.6

1.5

nmol/l

19.4

20.4

0.96

529

3914

(3019309) Folate [Moles/volume] in Red Blood Cells

578

3582

1.80

30.72

1.8

1.7

nmol/l

1145.5

1167.7

0.20

368

2736

(3001604) Monocytes [#/volume] in Blood

1329

10261

1.63

30.70

6.8

5.8

e9/l

0.6

1.32

1135

8921

(4146454)

208

4.09

29.83

2.7

2.6

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2294

20708

2.26

29.31

18.1

13.7

mg/l

22.8

23.3

0.30

1929

16318

(3023368) Bacteria identified in Blood by Culture

777

5301

1.67

28.96

4.3

4.4

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1485

11893

1.61

28.60

5.3

4.8

mmol/l

6.8

6.7

1.26

1408

11084

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1338

10459

1.60

28.49

5.7

6.2

umol/l

10.4

11.3

2.71

1245

9913

(3019198) Lymphocytes [#/volume] in Blood

1348

10579

1.59

28.04

6.9

5.9

e9/l

2.0

0.21

1177

9374

(3031040) Bacteria [#/volume] in Urine by Automated count

1639

13481

1.62

27.94

5.7

4.3

e6/l

3526.2

1591.0

0.31

200

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1116

8426

1.58

27.04

2.7

2.2

nmol/l

75.7

76.6

0.41

915

7628

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2110

18618

1.84

26.98

7.3

5.5

mmol/mol

40.7

39.6

5.35

1832

17289

(3019550) Sodium [Moles/volume] in Serum or Plasma

2314

21084

2.26

26.83

19.6

15.6

mmol/l

139.6

139.7

1.13

2241

20547

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1013

7496

1.59

26.63

4.3

3.5

ng/l

39.5

54.7

0.76

678

4957

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

124

4.85

26.47

1.4

1.3

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2316

21151

2.24

26.00

19.8

15.7

mmol/l

4.0

0.21

2236

20583

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

777

5419

1.63

26.00

3.1

3.0

ng/l

1150.2

1332.5

0.81

603

4601

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

506

3178

1.74

25.08

1.9

1.8

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

869

6305

1.58

24.28

2.9

2.5

u/l

54.8

57.2

0.69

783

5830

(3013650) Neutrophils [#/volume] in Blood by Automated count

1464

11964

1.54

23.58

9.5

8.9

e9/l

4.2

4.1

0.86

1262

10480

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2122

18948

1.78

23.52

5.8

4.7

mu/l

1.9

2.0

0.60

1831

17471

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1635

13746

1.54

22.64

3.8

3.1

u/l

46.4

47.5

0.23

1472

12872

(3032080) INR in Blood by Coagulation assay

1042

7966

1.53

22.56

8.1

9.0

inr

1.2

0.33

261

2297

(3009508) Creatinine [Moles/volume] in Urine

851

6242

1.55

22.19

3.8

3.2

mmol/l

7.4

7.6

0.69

636

5296

(3037522) Nuclear Ab [Titer] in Serum

443

2782

1.72

21.66

1.4

1.3

titre

433.1

527.7

0.60

575

(40768804) Tissue Pathology biopsy report

1072

8300

1.51

21.55

2.3

2.1

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

814

5966

1.54

21.05

2.2

2.1

u/l

162.8

233.9

1.73

759

5599

(3044640) Blood type and Crossmatch panel - Blood

872

6490

1.53

20.99

2.5

2.4

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

905

6793

1.52

20.92

3.2

3.4

mmol/l

2.4

0.52

656

5998

(4010399)

262

1418

1.95

20.79

1.5

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

161

730

2.29

20.34

1.9

1.8

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

249

3.24

20.29

1.9

2.2

mg/l

27.3

23.8

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

173

811

2.22

20.17

1.9

—

(40768797) Stomach Pathology biopsy report

442

2829

1.68

20.01

1.3

1.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2132

19284

1.70

19.76

15.8

12.6

ml/min/173m2

82.6

0.05

1749

15848

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2172

19779

1.73

19.20

5.5

4.4

mmol/l

6.1

5.9

6.75

1860

18120

(3017732) Neutrophils [#/volume] in Blood

258

1427

1.90

19.14

3.2

3.1

e9/l

5.1

4.1

1.07

129

1142

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

217

1142

1.99

18.63

1.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

592

4137

1.56

18.57

1.5

g/l

2.4

0.27

311

2545

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1822

15957

1.52

18.56

4.6

4.0

pmol/l

14.6

14.7

1.38

1556

14593

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

687

4965

1.53

18.49

2.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

720

5306

1.50

17.49

2.9

2.7

umol/l

4348.5

4892.8

0.13

569

4635

(3020682) Albumin/Creatinine [Ratio] in Urine

804

6067

1.48

17.33

4.7

4.0

mg/mmol

12.0

8.6

1.09

471

3845

(3012516) Albumin [Mass/volume] in Urine

771

5770

1.49

17.33

3.8

3.3

mg/l

454.9

368.6

0.18

450

3673

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

519

3571

1.57

17.27

1.3

iu/ml

25.6

32.3

0.61

129

1129

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

470

3165

1.60

17.13

3.4

2.9

e6/l

2.6

0.07

276

1709

(3048689) Calprotectin [Mass/mass] in Stool

392

2528

1.65

17.03

2.5

2.4

ug/g

134.6

127.1

0.18

290

2015

(3022145) Colonoscopy Study observation

354

2226

1.69

16.93

1.4

1.3

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1133

9156

1.43

16.86

3.4

2.8

ug/l

120.4

121.7

0.04

993

8501

(40761511) CBC panel - Blood by Automated count

2310

21585

1.89

16.50

18.1

12.8

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2334

21939

1.92

15.52

12.7

10.1

u/l

27.3

26.3

1.72

2203

21215

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

488

3411

1.53

14.90

1.3

1.2

u/ml

5.2

11.0

1.67

137

1361

(3026008) Bacteria identified in Urine by Culture

783

6026

1.44

14.70

3.5

3.0

—

(3002582) Erythrocytes [#/volume] in Urine

786

6069

1.43

14.44

4.0

3.2

e6/l

46.4

93.9

1.35

609

4653

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

482

3393

1.52

14.17

3.2

2.7

e6/l

1.1

0.06

285

1923

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

615

4554

1.46

14.07

2.1

1.8

mg/l

1.1

1.2

0.12

435

3467

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1560

13586

1.39

13.81

3.3

3.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

228

1340

1.77

13.81

1.5

1.3

u/ml

260.1

221.9

0.20

211

1245

(3022217) INR in Platelet poor plasma by Coagulation assay

365

2430

1.59

13.74

24.5

24.1

inr

1.3

0.01

362

(3000570) Elastase.pancreatic [Mass/mass] in Stool

121

577

2.15

13.55

1.6

1.4

ug/g

298.1

283.9

0.28

326

(3008757) Leukocyte morphology finding [Identifier] in Blood

213

2.91

13.25

3.5

4.3

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

4.04

13.09

1.1

1.0

u/ml

11.6

11.9

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

294

2.60

13.08

1.5

1.4

u/l

21.9

25.9

0.48

243

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2097

19348

1.51

12.86

4.6

3.8

mmol/l

1.4

1.3

6.85

1786

17817

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

251

2.72

12.79

1.6

1.5

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

854

6806

1.39

12.70

3.3

3.2

u/l

30.5

33.4

1.31

814

6471

(3024561) Albumin [Mass/volume] in Serum or Plasma

1045

8607

1.37

12.66

5.4

4.9

g/l

35.7

35.6

0.24

952

8017

(3022948) Iron [Moles/volume] in Serum or Plasma

440

3106

1.51

12.64

3.0

2.5

umol/l

12.7

13.4

1.27

394

2868

(3005988) Vibrio sp identified in Specimen by Organism specific culture

253

2.69

12.60

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

130

656

2.04

12.56

1.8

1.7

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

623

4715

1.43

12.46

1.3

u/ml

0.7

1.7

4.44

112

1262

(3018095) Leukocytes [#/volume] in Urine

890

7160

1.38

12.43

4.7

3.6

e6/l

87.4

106.8

0.34

644

5026

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

671

5153

1.41

12.34

2.5

2.2

mg/l

2.9

0.05

551

4396

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

256

2.66

12.32

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

252

2.66

12.15

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

252

2.66

12.15

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

254

2.64

11.97

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

256

2.62

11.79

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

249

2.61

11.38

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2163

20200

1.51

11.35

5.1

4.3

mmol/l

4.5

4.7

8.33

1876

18820

(3004789) Transferrin [Mass/volume] in Serum or Plasma

403

2855

1.49

11.28

3.0

2.5

g/l

2.4

2.3

1.11

360

2642

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

6.47

11.09

1.5

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2192

20549

1.53

11.08

5.5

4.7

mmol/l

2.7

2.8

4.09

1880

19012

(3003458) Phosphate [Moles/volume] in Serum or Plasma

378

2670

1.49

10.70

7.4

5.8

mmol/l

1.0

0.04

346

2483

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

333

2294

1.52

10.63

2.6

2.8

umol/l

6.9

7.9

0.43

280

1984

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

375

2650

1.49

10.59

3.1

2.6

21.8

23.4

1.43

309

2264

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2146

20069

1.48

10.57

5.3

4.2

mmol/l

1.4

1.5

14.67

1843

18585

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1145

9740

1.32

10.50

4.2

4.1

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

173

1020

1.75

10.37

3.2

2.8

e6/l

0.3

0.17

168

993

(3005719) IgG [Mass/volume] in Serum or Plasma

242

1561

1.61

10.31

2.8

g/l

10.1

10.5

0.90

210

1436

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

320

2209

1.51

10.10

1.8

1.7

—

(36660697) Celiac disease serology panel - Serum

255

1674

1.58

10.09

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

2051

19073

1.41

9.91

19.2

14.7

39.6

39.8

0.35

1346

13996

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

138

779

1.82

9.60

1.5

1.6

—

(3007461) Platelets [#/volume] in Blood

2395

23062

1.85

9.51

26.9

20.1

e9/l

252.3

252.6

0.08

2344

22485

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

182

1118

1.68

9.41

1.1

1.0

—

(3035941) MCH [Entitic mass]

2395

23077

1.84

9.27

26.7

20.0

30.1

30.3

3.58

2363

22763

(3026361) Erythrocytes [#/volume] in Blood

2395

23078

1.84

9.25

26.9

20.1

e12/l

4.5

0.19

2339

22435

(3033658) Prothrombin time (PT) actual/Normal

644

5115

1.35

9.20

4.3

3.9

91.8

90.8

0.45

625

4984

(3010813) Leukocytes [#/volume] in Blood

2395

23085

1.83

9.14

26.9

20.1

e9/l

7.0

6.7

3.51

2338

22443

(3024731) MCV [Entitic volume]

2394

23073

1.83

9.13

26.8

20.0

90.6

90.9

2.35

2362

22762

(3000963) Hemoglobin [Mass/volume] in Blood

2395

23087

1.83

9.11

27.1

20.2

g/l

134.9

135.3

0.65

2362

22774

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

439

2.04

8.86

1.5

1.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

220

1439

1.58

8.84

1.7

—

(3030467) Casts [#/volume] in Urine by Automated count

687

5543

1.33

8.75

3.9

3.1

e6/l

0.4

0.32

511

4173

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

114

626

1.86

8.68

3.4

2.7

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

227

1503

1.56

8.65

4.7

4.0

ng/l

107.6

86.3

1.68

181

1320

(3004809) Band form neutrophils/100 leukocytes in Blood

325

2.19

8.50

4.1

3.5

1.1

1.5

0.76

260

(3027945) Reticulocytes/100 erythrocytes in Blood

310

2207

1.46

8.36

2.7

2.8

1.7

1.8

1.03

263

1966

(3012095) Magnesium [Moles/volume] in Serum or Plasma

430

3252

1.39

8.27

3.7

3.5

mmol/l

0.8

1.91

395

3051

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

310

2221

1.45

8.08

1.8

—

(3014271) Vancomycin [Susceptibility]

3.40

8.07

3.4

2.8

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

193

2.52

8.07

3.9

3.2

58.0

55.3

0.25

128

(3004588) Protein electrophoresis panel - Serum or Plasma

200

1310

1.57

8.00

2.4

2.5

—

(3023520) Reticulocytes [#/volume] in Blood

237

1621

1.51

7.79

2.5

2.7

e9/l

67.0

70.5

0.90

191

1237

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

163

1026

1.63

7.70

2.4

—

(3037121) Protein [Mass/volume] in Urine

124

730

1.73

7.53

3.1

3.4

g/l

0.3

0.05

301

(36304419) Bacteria [Presence] in Urine

662

5420

1.30

7.39

3.8

3.0

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

178

1158

1.58

7.34

1.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

129

775

1.70

7.29

1.3

1.2

u/ml

0.2

1.0

—

(3028026) IgM [Mass/volume] in Serum or Plasma

187

1237

1.55

7.18

1.9

1.8

g/l

1.3

1.4

0.10

160

1142

(1761868) Lipid panel - Serum or Plasma

608

7366

0.77

7.12

3.1

2.7

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

133

812

1.67

7.09

2.1

u/l

399.7

4307.3

5.38

333

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

484

3818

1.33

7.02

3.7

3.6

ng/l

232.3

461.7

1.81

342

2878

(3038026) Centromere Ab [Units/volume] in Serum

159

2.54

6.93

1.1

—

54.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

529

4238

1.31

6.87

1.7

pmol/l

15404459.7

29073462.2

0.36

396

3560

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

262

1878

1.44

6.80

2.6

2.4

u/l

28.0

63.6

0.79

218

1613

(3017143) Hepatitis C virus Ab [Presence] in Serum

328

2447

1.39

6.79

1.8

1.6

—

(3023511) Choriogonadotropin [Units/volume] in Urine

448

1.88

6.74

1.6

1.3

—

(3020630) Protein [Mass/volume] in Serum or Plasma

227

1586

1.47

6.73

2.4

2.8

g/l

66.6

66.5

0.08

178

1462

(40768443) Skin Pathology biopsy report

136

848

1.64

6.70

1.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

206

2.31

6.61

1.1

1.2

u/l

63.2

60.5

0.09

147

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

190

1285

1.52

6.60

1.3

au/ml

62.9

52.0

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

112

668

1.71

6.53

1.7

1.5

titre

50.0

242.3

—

(3000850) Epithelial cells [#/volume] in Urine

526

4246

1.30

6.42

3.1

2.5

e6/l

5.8

6.1

0.12

460

3719

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

298

2217

1.39

6.27

3.8

4.2

u/l

235.6

246.6

0.69

268

2097

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

416

1.88

6.26

1.1

1.2

—

10.9

—

(40758558) Short blood count panel - Blood

626

5192

1.27

6.15

7.3

6.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

262

1914

1.41

6.12

2.5

2.3

g/l

0.2

0.15

229

1782

(3020779) Urea [Moles/volume] in Serum or Plasma

246

1780

1.42

6.07

10.7

7.4

mmol/l

9.7

9.6

0.03

223

1699

(3026782) Osmolality of Urine

485

3910

1.30

5.93

3.4

2.7

mosm/kgh2o

554.5

551.2

0.11

400

3327

(3014111) Lactate [Moles/volume] in Serum or Plasma

239

1729

1.42

5.91

7.7

7.5

mmol/l

1.2

1.4

1.88

226

1668

(3032057) Clostridioides difficile [Presence] in Stool

4.19

5.82

1.3

2.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

487

3939

1.29

5.80

1.6

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

132

2.52

5.70

1.1

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

112

695

1.64

5.67

1.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

550

1.72

5.64

1.2

titre

136.7

109.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

176

2.29

5.63

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

353

1.89

5.57

2.5

2.7

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

261

1938

1.39

5.55

2.1

nmol/l

388.7

372.9

0.62

228

1784

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

134

2.48

5.53

1.1

1.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

108

672

1.63

5.42

2.4

2.3

ug/l

394.5

517.5

0.29

101

630

(3026389) Candida sp identified in Specimen by Organism specific culture

259

2.03

5.39

1.6

1.3

—

(3045414) Leukocytes [Presence] in Urine

139

920

1.54

5.38

1.8

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

111

697

1.62

5.38

2.4

2.5

g/l

10.6

10.2

0.27

592

(3021447) Carbon dioxide [Partial pressure] in Venous blood

251

1863

1.39

5.36

5.3

3.8

kpa

5.9

5.8

0.31

245

1807

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

155

2.34

5.33

1.1

—

61.3

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

129

845

1.56

5.24

2.6

1.5

u/ml

13.2

21.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

332

1.89

5.24

1.2

1.3

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

108

2.61

5.22

1.1

u/l

14.6

28.0

1.30

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

157

2.31

5.19

1.1

—

67.7

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

323

2507

1.33

5.17

2.5

2.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

526

1.70

5.16

1.2

u/ml

14.1

9.5

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

306

1.92

5.13

1.8

1.9

—

4.6

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

120

779

1.57

5.08

2.0

ug/l

2.1

2.2

0.04

694

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

116

748

1.58

5.05

2.5

g/l

3.7

3.8

0.26

543

(3024980) IgG subclass 4 [Mass/volume] in Serum

322

1.88

5.05

1.2

1.6

g/l

0.5

0.7

1.97

254

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

116

749

1.58

5.03

2.5

g/l

7.6

7.3

0.78

570

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

116

749

1.58

5.03

2.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

481

3957

1.27

4.95

1.9

1.8

—

(3021788) Differential panel - Synovial fluid

362

1.82

4.88

1.5

1.6

—

(3025941) Bacteria identified in Stool by Culture

165

1159

1.45

4.82

1.2

—

(3011288) Drugs identified in Urine by Screen method

537

1.66

4.80

2.8

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

382

3065

1.29

4.80

2.4

2.1

29.5

29.8

0.30

367

2966

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

100

633

1.60

4.73

1.6

iu/ml

0.1

10.4

0.50

117

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

293

2272

1.33

4.72

2.5

2.0

—

(3045424) Erythrocytes [Presence] in Urine

344

1.82

4.72

1.3

1.5

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

109

707

1.57

4.65

2.6

2.5

g/l

3.3

3.1

0.70

556

(3024354) Oxygen [Partial pressure] in Venous blood

208

1534

1.39

4.63

4.6

3.2

kpa

4.9

4.6

0.88

203

1485

(3022621) pH of Urine by Test strip

183

1321

1.42

4.62

4.0

2.8

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

599

1.61

4.57

1.6

1.4

u/l

11.1

9.6

0.61

485

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

147

1023

1.46

4.52

9.7

10.3

mmol/l

24.7

24.3

0.88

135

962

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.87

4.49

1.9

1.7

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

3.60

4.48

1.4

1.6

ug/l

0.4

0.3

—

(3049717) Cytology report of Urine Cyto stain

112

738

1.54

4.47

3.2

2.6

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

587

1.61

4.47

2.2

2.4

g/l

37.5

37.7

0.11

511

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

105

2.49

4.46

1.2

1.7

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

143

993

1.47

4.45

5.0

4.3

mmol/l

23.9

24.0

0.21

127

907

(3017181) Myelocytes/100 leukocytes in Blood

224

1688

1.36

4.38

4.9

4.1

0.8

0.9

0.13

496

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

420

1.71

4.38

2.0

2.1

nmol/l

1.0

0.8

0.47

353

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

177

1283

1.41

4.37

3.5

3.4

pmol/l

4.4

4.5

0.49

144

1139

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

183

2.09

4.37

1.2

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

183

2.09

4.37

1.2

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

183

2.09

4.37

1.2

1.5

—

(3002619) Bacteria identified in Specimen by Culture

3.73

4.36

1.3

1.1

—

(3002032) Base excess in Venous blood by calculation

243

1857

1.34

4.34

5.4

3.9

mmol/l

1.6

1.9

0.73

207

1478

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

400

3270

1.27

4.31

1.7

1.6

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

424

1.69

4.24

6.2

5.3

iu/ml

354.0

759.3

0.58

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

509

1.63

4.23

1.3

1.6

—

(3018418) pH of Serum or Plasma

677

5868

1.21

4.22

4.6

4.0

7.4

0.31

1119

(21494755) Public health laboratory ask at order entry panel

144

2011

0.70

4.22

1.4

1.3

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

133

2.27

4.22

2.3

2.7

e9/l

0.3

0.2

0.93

116

(3002179) Metamyelocytes/100 leukocytes in Blood

205

1534

1.37

4.20

4.1

3.9

0.5

0.6

0.50

352

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

637

1.56

4.18

1.3

1.9

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.09

4.16

1.4

1.0

—

(3000330) Specific gravity of Urine by Test strip

139

975

1.45

4.13

4.5

3.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

320

2559

1.29

4.12

1.9

1.8

1.5

0.91

270

2245

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

584

1.58

4.11

1.4

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

116

2.34

4.08

1.0

—

(3000475) Leukocytes [#/volume] in Synovial fluid

485

1.63

4.01

1.6

1.7

e6/l

21330.6

15364.9

0.30

355

(3021440) Promyelocytes/100 leukocytes in Blood

211

1599

1.35

3.99

4.9

4.1

0.1

0.41

456

(3025159) Blasts/100 leukocytes in Blood

200

1504

1.36

3.98

4.9

4.2

0.2

0.5

0.38

378

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

105

2.39

3.98

1.2

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

105

2.39

3.98

1.2

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

105

2.39

3.98

1.2

1.7

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

557

1.58

3.98

1.9

1.7

nmol/l

51.0

40.3

0.63

541

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

700

6118

1.20

3.96

5.3

4.8

ug/l

4.5

3.5

0.23

588

5495

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

216

1646

1.34

3.94

2.3

2.4

ug/l

5.9

6.9

0.60

150

1481

(3034860) Kappa light chains.free [Mass/volume] in Serum

598

1.56

3.94

2.8

3.7

mg/l

47.7

66.7

0.59

484

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

199

1500

1.35

3.90

1.2

iu/ml

143.2

157.5

0.19

585

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.27

3.90

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

3.27

3.90

1.2

1.3

ug/l

3.1

87.6

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.27

3.90

1.9

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

125

870

1.46

3.88

1.4

1.9

u/l

38.4

38.8

0.10

103

776

(3011412) CD3 cells [#/volume] in Blood

192

1.99

3.88

2.1

2.5

e9/l

1.1

0.06

116

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

136

1888

0.70

3.87

1.7

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

601

1.55

3.86

2.8

3.7

mg/l

65.4

50.6

0.19

488

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

139

2.17

3.83

2.2

2.6

e6/l

640.8

509.6

0.73

117

(3017446) Testosterone [Moles/volume] in Serum or Plasma

189

1419

1.36

3.81

2.4

2.1

nmol/l

11.7

12.6

0.65

154

1264

(3013139) Helicobacter pylori Ag [Presence] in Stool

177

1316

1.37

3.79

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

140

2.16

3.77

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

371

1.69

3.72

1.0

1.1

u/ml

3.7

2.9

0.14

(4198724)

2.58

3.71

2.0

1.8

—

(3051593) INR in Capillary blood by Coagulation assay

2.51

3.71

2.6

13.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.80

3.69

2.7

2.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

282

1.79

3.68

1.3

1.5

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.44

3.62

1.0

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

539

1.56

3.60

1.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

644

1.51

3.60

2.3

2.6

g/l

1.1

0.04

565

(3014133) Dog dander IgE Ab [Units/volume] in Serum

307

1.74

3.58

1.0

u/ml

2.1

3.7

0.68

124

(3009466) Valproate [Moles/volume] in Serum or Plasma

295

1.74

3.47

4.5

5.6

umol/l

376.1

365.9

0.19

260

(3027923) C peptide [Moles/volume] in Serum or Plasma

119

2.20

3.44

1.9

1.4

nmol/l

1.2

0.04

(3023430) Cat dander IgE Ab [Units/volume] in Serum

281

1.76

3.44

1.0

1.1

u/ml

14.6

4.8

0.36

122

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

230

1.84

3.42

1.1

1.3

nmol/l

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

146

2.07

3.42

1.1

—

3.8

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

396

1.63

3.41

2.0

1.8

pmol/l

200.0

198.2

0.04

378

(1761482) Bacteria [#/volume] in Urine by Culture

467

1.58

3.40

5.7

4.5

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

420

1.61

3.39

1.5

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

420

1.61

3.39

1.5

1.3

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

2.45

3.38

1.3

1.8

ug/l

28.2

117.6

0.43

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

7.01

3.36

3.0

3.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

203

1.89

3.35

1.1

1.3

—

(3003396) Base excess in Arterial blood by calculation

277

2235

1.27

3.34

7.3

8.1

mmol/l

1.2

1.1

0.31

202

1732

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

190

1.91

3.29

3.7

2.6

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

625

1.49

3.27

1.4

1.7

g/l

1.3

1.2

1.98

589

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.39

3.22

1.2

1.8

—

(40768446) Kidney Pathology biopsy report

2.45

3.21

1.8

1.6

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

514

1.53

3.21

3.6

3.2

mmol/l

24.1

24.9

0.90

445

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.34

3.19

5.5

6.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

248

1986

1.28

3.19

2.9

4.2

ug/l

53.7

18.7

0.53

189

1617

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

130

2.09

3.18

1.3

1.6

u/l

16.3

7.8

0.60

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

117

2.15

3.16

1.0

1.1

—

(3002256) Pathology report gross observation

318

2625

1.24

3.15

1.3

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

244

1.78

3.15

1.7

1.6

55.3

61.4

0.43

159

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

151

2.00

3.15

1.7

2.5

12.5

14.3

0.37

(40761535) Cells panel - Urine sediment

207

1623

1.30

3.14

3.9

3.4

—

(3001556) Androgen free Index in Serum or Plasma

4.51

3.11

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

567

1.50

3.10

2.0

1.8

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

166

1.94

3.09

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

400

1.59

3.06

1.0

1.1

u/ml

7.6

5.9

0.27

221

(3048879) Bone marrow aspiration report

2.69

3.05

1.4

1.9

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

362

1.62

3.02

1.3

1.5

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

120

872

1.40

3.01

1.8

1.9

g/l

1.6

1.5

0.30

106

760

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

111

796

1.41

3.01

4.2

6.3

1.8

1.6

0.88

104

735

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

604

1.47

3.00

1.4

1.7

g/l

0.3

0.2

0.95

570

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

419

1.57

2.97

1.6

1.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

228

1.77

2.91

1.5

g/l

32.6

32.5

0.01

205

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

422

1.55

2.89

1.2

u/ml

19.0

46.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

586

1.47

2.85

1.1

u/ml

2.8

5.0

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.30

2.84

1.6

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.30

2.84

1.6

1.4

—

(3006653) Thiamine [Moles/volume] in Blood

116

2.08

2.82

2.1

1.3

nmol/l

140.3

136.3

0.16

116

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

272

2236

1.24

2.82

7.4

8.1

kpa

5.2

5.1

0.50

253

2134

(4062490)

201

1.80

2.81

1.3

1.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.21

2.73

2.2

2.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

404

1.55

2.73

1.3

—

(3027801) Oxygen [Partial pressure] in Arterial blood

271

2237

1.24

2.71

7.4

8.1

kpa

11.9

12.4

1.00

251

2135

(3016502) Oxygen saturation in Arterial blood

245

2000

1.25

2.71

7.8

8.6

94.7

95.8

1.44

230

1922

(3012494) Peanut IgE Ab [Units/volume] in Serum

2.43

2.71

1.1

u/ml

2.2

13.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

494

1.49

2.70

1.4

1.6

—

(3008898) HLA-B27 [Presence]

104

753

1.40

2.70

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

430

1.53

2.68

1.3

1.6

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

382

1.56

2.68

1.6

1.4

u/ml

182.4

121.4

0.36

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

520

1.48

2.67

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1274

0.71

2.65

1.6

1.4

—

(3028626) Oxygen [Partial pressure] in Capillary blood

490

1.48

2.61

4.5

3.4

kpa

8.9

8.2

2.20

445

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

450

1.50

2.59

1.3

1.2

—

(3000991) Gas panel - Venous blood

208

1676

1.26

2.58

10.7

8.7

—

(3003338) MCHC [Mass/volume]

1704

17765

0.87

2.58

22.6

17.5

g/l

332.0

332.5

1.80

1698

17623

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

3.61

2.57

1.4

1.0

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

201

1615

1.27

2.56

2.4

2.8

ng/l

139.4

193.4

2.61

185

1468

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

7.15

2.55

5.2

3.1

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

7.15

2.55

5.2

3.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

528

4664

1.17

2.53

3.8

3.5

—

(3035350) Ketones [Presence] in Urine by Test strip

1078

10009

1.14

2.53

4.2

3.5

estimate

0.0

0.00

170

1868

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

108

2.05

2.51

1.0

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

569

1.44

2.51

1.1

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

294

2470

1.22

2.49

7.8

7.1

mmol/l

104.6

104.5

0.27

284

2407

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.47

2.48

1.2

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.20

2.47

2.3

3.2

umol/l

65.6

144.1

1.74

(3021879) Hepatitis B virus core Ab [Presence] in Serum

194

1562

1.26

2.44

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

623

1.41

2.43

2.2

2.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

441

1.49

2.41

1.1

u/ml

6.6

1.9

0.75

195

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

557

1.43

2.41

1.3

—

(21494815) CD4 cells/100 lymphocytes in Specimen

167

1.81

2.40

2.1

2.4

23.4

45.9

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

106

787

1.36

2.40

4.2

6.3

0.9

0.16

728

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

125

1.93

2.35

1.5

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.15

2.34

1.2

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.15

2.34

1.2

1.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

363

1.53

2.33

1.3

1.7

—

(3009261) Glucose [Presence] in Urine by Test strip

1087

10135

1.13

2.33

4.3

3.6

estimate

0.0

1.08

168

1839

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

323

1.56

2.33

1.4

1.5

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

199

1.72

2.32

1.2

1.4

g/l

0.4

0.11

143

(3027135) IgG subclass 1 [Mass/volume] in Serum

199

1.72

2.32

1.2

1.4

g/l

6.5

6.7

0.14

144

(3028192) IgG subclass 2 [Mass/volume] in Serum

199

1.72

2.32

1.2

1.4

g/l

2.5

2.8

0.58

143

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

162

1.80

2.31

1.7

1.3

u/ml

1.5

0.6

0.33

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.19

2.31

1.0

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

2.19

2.31

1.8

2.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

479

1.45

2.30

2.3

2.4

ug/min

227.2

114.4

0.62

302

(3042733) HLA Ab [Presence] in Serum

2.38

2.29

5.0

4.8

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

153

0.33

2.28

2.0

1.5

g/l

1.0

—

153

(3023383) Lactate [Moles/volume] in Pleural fluid

2.46

2.27

1.2

1.4

mmol/l

2.5

3.3

0.50

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.56

2.27

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

390

1.50

2.26

1.0

1.1

u/ml

1.3

1.4

0.04

180

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

391

1.49

2.24

1.5

1.6

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

225

1.65

2.21

1.3

1.4

pmol/l

327.9

305.7

0.09

170

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

568

1.40

2.19

1.6

1.7

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

329

1.53

2.17

4.5

2.9

u/ml

9710.8

1881.0

—

(3016879) Cocaine [Presence] in Urine

741

1.35

2.16

2.5

2.1

—

(4035726)

214

1769

1.23

2.15

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

338

1.52

2.14

1.1

iu/ml

233.3

1626.6

—

(3023419) Bacteria identified in Sputum by Culture

251

1.60

2.13

3.6

2.9

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.37

2.12

1.0

1.3

—

(3044927) Protein electrophoresis panel - Urine

205

1.67

2.11

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

138

1.82

2.09

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

198

1.68

2.09

1.6

1.4

e6/l

39003.4

67270.7

0.34

135

(3023199) Leukocytes [#/volume] in Pleural fluid

214

1.64

2.06

1.5

1.4

e6/l

3669.8

1693.3

0.41

145

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

176

1.71

2.06

1.2

1.3

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

534

1.40

2.03

2.4

2.5

g/l

0.0

0.00

490

(3000764) Benzodiazepines [Presence] in Urine

104

795

1.32

1.99

2.5

2.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

446

1.42

1.94

3.1

3.9

—

(3012441) Differential panel - Pleural fluid

180

1.67

1.92

1.6

1.4

—

(3027008) Opiates [Presence] in Urine

104

800

1.31

1.92

2.4

2.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

1067

10023

1.11

1.89

6.0

4.8

estimate

0.0

0.50

175

1904

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

173

1.68

1.89

1.1

1.0

mg/l

316.3

289.0

1.15

157

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

533

1.38

1.89

1.2

1.5

mg/l

471.7

510.9

0.32

503

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

212

1.61

1.88

1.3

1.6

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.16

1.88

1.0

1.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

292

1.52

1.87

1.1

g/l

1.5

0.36

263

(3036489) Thrombin time

102

786

1.31

1.86

2.3

20.7

21.2

0.70

688

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.65

1.86

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.65

1.86

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.65

1.86

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

174

1.67

1.86

3.1

3.5

mg/l

58.6

44.3

0.23

130

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

425

1.42

1.85

1.3

1.2

u/ml

222.3

263.1

0.63

255

(3028300) Cannabinoids [Presence] in Urine

104

805

1.30

1.84

2.5

2.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

261

1.54

1.84

1.0

u/ml

0.1

0.4

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

3.54

1.83

4.0

5.5

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

168

1.67

1.80

1.2

1.3

nmol/l

1.4

0.03

150

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.92

1.80

1.6

1.9

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

123

1.80

1.0

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

153

1.71

1.79

3.0

1.6

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

530

1.37

1.79

2.4

2.5

g/l

0.0

0.00

489

(3047007) Chlamydophila sp Ab [Presence] in Serum

320

1.48

1.79

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

591

1.35

1.78

3.0

3.3

—

(3021901) Oxygen saturation in Capillary blood

362

1.45

1.77

3.2

2.9

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

109

1.84

1.77

1.6

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

472

1.39

1.76

2.5

2.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

185

1.63

1.75

1.2

1.0

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

1.90

1.75

1.6

1.7

nmol/l

4.7

5.6

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

567

1.35

1.75

2.4

g/l

0.0

0.15

521

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

289

1.50

1.75

1.5

1.6

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

322

1.47

1.74

1.0

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

629

1.33

1.72

1.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

290

1.49

1.72

1.4

1.6

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.92

1.72

1.1

1.9

umol/l

42.7

47.5

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.85

1.71

1.2

1.0

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

2.30

1.70

3.4

3.6

ng/l

128.1

90.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.30

1.70

1.2

1.0

—

(3028433) Virus identified in Specimen by Culture

2.06

1.70

1.0

1.3

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

0.00

1.69

0.0

1.8

—

1.8

—

(40768806) Pleura Pathology biopsy report

188

1.60

1.66

1.6

1.5

—

(40768795) Lymph node Pathology biopsy report

189

1.59

1.63

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

105

1.82

1.63

4.8

3.8

—

(3020491) Glucose [Moles/volume] in Blood

143

1.68

1.61

1.7

2.1

mmol/l

7.7

7.1

0.44

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

716

1.30

1.60

1.3

1.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

141

1156

1.23

1.60

1.9

1.8

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.07

1.59

1.8

2.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.07

1.59

1.8

2.7

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

236

0.51

1.59

1.3

1.2

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

1.89

1.55

1.3

1.8

umol/l

2.3

2.0

0.64

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

107

1.78

1.54

1.7

1.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

191

1620

1.19

1.54

4.0

2.6

ml/min/173m2

71.2

68.1

0.52

618

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

193

1.56

1.51

1.3

1.7

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

146

1.65

1.50

2.4

e6/l

819.1

692.0

0.44

(3024928) Oxygen saturation in Venous blood

435

1.36

1.50

3.4

—

(4211845)

101

1.79

1.48

4.1

3.2

—

(3019150) Specific gravity of Urine by Refractometry

485

4416

1.12

1.48

4.7

3.9

kg/l

1.0

0.27

640

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

672

1.29

1.47

1.3

miu/ml

265.2

225.3

0.43

314

(3006462) Nitrate [Presence] in Urine

1.81

1.47

4.3

3.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

235

1.50

1.47

1.3

1.6

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

285

1.45

2.0

2.4

u/ml

4908.0

62.8

0.48

267

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.50

1.45

1.4

1.5

ng/l

101.7

122.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

173

1464

1.20

1.45

2.0

1.9

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

125

1.69

1.43

1.3

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.00

1.38

1.2

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

583

1.30

1.36

1.2

—

(3027944) Amphetamines [Presence] in Urine

789

1.25

1.34

2.5

2.0

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

540

1.30

1.34

7.1

4.2

mg/l

1.6

1.5

0.27

499

(3044941) Cell count panel - Synovial fluid

316

1.40

1.33

1.3

1.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

144

1.60

1.32

1.7

2.5

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

192

1.52

1.32

4.6

3.9

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

385

1.36

1.32

2.0

1.7

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1018

0.79

1.31

1.3

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

193

1.51

1.29

1.6

1.4

e6/l

278680.2

77988.2

0.53

107

(3017817) Protein [Mass] in Urine collected for unspecified duration

185

1.52

1.29

2.2

2.7

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

405

1.34

1.27

1.2

—

(3000492) Spirometry study

228

2001

1.15

1.25

1.6

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

253

1.43

1.24

1.1

1.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.00

1.23

1.1

1.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

139

1.59

1.23

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.91

1.22

1.2

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

229

1.45

1.22

1.4

1.7

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

230

1.44

1.19

2.3

2.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.84

1.19

1.0

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

259

2304

1.14

1.18

1.7

—

(3005570) Glucose [Moles/volume] in Urine

214

1.45

1.18

2.4

2.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.93

1.17

1.0

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

282

1.39

1.16

1.3

1.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

257

1.41

1.15

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

380

0.68

1.15

1.2

1.5

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.50

1.15

1.2

—

(3017509) Phencyclidine [Presence] in Urine

2.50

1.15

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

545

1.27

1.14

1.3

2.1

mg/l

12.0

11.2

0.41

499

(3021589) Normoblasts [#/volume] in Blood

961

9149

1.08

1.14

11.0

9.3

e9/l

0.0

0.19

771

7486

(21494890) Protein electrophoresis panel - 24 hour Urine

199

1.46

1.14

1.5

2.3

—

(3003181) Sodium [Moles/volume] in Urine

335

1.35

1.13

1.2

1.4

mmol/l

60.3

63.1

0.21

271

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

127

1.58

1.11

1.4

1.5

—

(3047189) Immunofixation for 24 hour Urine

1.71

1.11

1.3

1.7

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.96

1.11

1.1

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

2.38

1.09

1.8

3.2

mg/l

3.2

2.2

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.95

1.08

1.0

1.3

—

191.3

—

(3020874) Milk IgE Ab [Units/volume] in Serum

128

1.57

1.08

1.1

1.0

u/ml

1.9

2.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

338

1.34

1.08

1.2

u/l

18.6

39.0

1.57

285

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

501

0.73

1.08

1.3

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

432

0.71

1.07

1.3

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

613

1.25

1.07

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.76

1.06

3.0

2.5

—

(4015189)

1.93

1.06

1.8

2.5

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.12

1.05

1.0

1.2

—

(3005033) Fetal Nuchal fold Thickness US

429

0.72

1.04

1.3

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

393

1.30

1.04

1.5

1.4

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.96

1.03

5.2

2.8

—

(3023183) Ammonium ion [Moles/volume] in Plasma

429

1.29

1.03

2.6

3.0

umol/l

33.5

35.4

0.28

361

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

114

1.58

1.02

1.5

1.6

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

450

0.73

1.02

1.5

1.7

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

163

1.48

1.01

1.4

1.7

—

(3035320) C reactive protein [Mass/volume] in Body fluid

147

1.50

1.00

3.6

2.1

—

(3024869) Neuronal Ab [Presence] in Serum

2.00

1.00

1.1

—

(44790049)

248

1.38

0.99

1.3

1.5

—

(44790048)

248

1.38

0.99

1.3

1.5

—

(44790047)

248

1.38

0.99

1.3

1.5

—

(44806118)

248

1.38

0.99

1.3

1.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

620

1.23

0.99

1.1

1.2

—

(3024932) HLA-DR beta [Type]

1.81

0.98

1.0

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.78

0.94

1.1

1.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

443

0.74

0.94

1.3

1.5

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

117

1.54

0.93

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

117

1.54

0.93

1.1

1.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.72

0.92

1.0

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

134

1.50

0.91

1.5

1.6

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

610

1.22

0.89

1.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

393

3642

1.09

0.89

2.9

3.0

mmol/l

2.4

0.27

332

3204

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

185

1.41

0.89

1.3

1.4

mmol/l

13.3

11.7

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

570

5373

1.08

0.86

1.7

1.6

mmol/l

1.4

0.70

500

4543

(40761536) Microorganisms panel - Urine sediment

157

1775

0.88

0.86

4.3

3.7

—

(3002385) Erythrocyte distribution width [Ratio]

1701

17376

0.93

0.86

22.1

16.6

13.7

13.6

0.36

1680

16975

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

123

1066

1.16

0.86

10.9

11.3

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.67

0.85

1.2

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

344

1.28

0.84

1.3

1.2

—

(3035880) pH of Pleural fluid

104

1.54

0.84

1.3

1.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.57

0.84

1.3

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

722

0.81

0.83

1.5

—

(3020891) Body temperature

765

0.82

0.83

4.9

4.5

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.74

0.82

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.74

0.82

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.74

0.82

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.74

0.82

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

435

1.25

0.82

2.5

2.2

g/l

132.4

130.6

0.20

322

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.70

0.80

1.1

1.5

—

(3029075) Extractable nuclear Ab panel - Serum

1.73

0.79

1.1

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.79

0.0

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.82

0.79

1.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

106

1.51

0.79

1.9

2.1

ug/min

58.6

191.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

357

1.27

0.78

1.0

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

216

1.35

0.78

1.7

—

(3036670) Protein [Mass/volume] in Synovial fluid

1.67

0.78

1.3

g/l

46.8

39.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.62

0.78

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.77

0.0

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

359

1.26

0.76

1.0

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

149

1.41

0.75

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

149

1.41

0.75

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

149

1.41

0.75

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

227

2069

1.11

0.75

1.7

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

253

1.31

0.75

1.1

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

532

1.21

0.75

1.7

2.0

iu/l

4.6

4.8

0.05

195

(3042631) Mycobacterium sp identified in Specimen

262

1.30

0.74

2.4

2.8

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.09

0.74

1.6

1.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

144

1617

0.88

0.74

6.0

3.7

mmol/l

1.2

0.10

127

1400

(3002173) Hemoglobin [Mass/volume] in Arterial blood

205

1861

1.11

0.73

8.8

8.9

g/l

122.9

121.7

0.38

197

1785

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.64

0.73

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

150

1.40

0.73

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

150

1.40

0.73

1.1

—

(44813793)

142

1.41

0.72

1.1

1.0

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

151

1.39

0.71

1.1

—

(3037756) Immunofixation for Serum or Plasma

408

1.23

0.70

1.6

1.7

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.92

0.70

1.6

1.4

—

(3047181) Lactate [Moles/volume] in Blood

629

1.18

0.69

4.7

7.6

mmol/l

1.2

1.3

0.57

544

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.53

0.69

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.85

0.68

1.0

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

380

3565

1.08

0.67

3.3

3.0

ug/l

0.7

0.8

0.61

238

2314

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

102

893

1.15

0.67

3.6

2.8

0.7

0.10

861

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.63

0.66

1.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

660

1.17

0.66

3.9

3.1

u/ml

0.3

0.60

363

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.54

0.65

1.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

137

1226

1.12

0.65

5.2

7.6

mmol/l

24.6

24.5

0.12

123

1137

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.59

0.65

2.1

umol/l

16.1

16.6

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

350

1.23

0.64

6.7

3.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.73

0.64

2.8

2.2

—

(3011648) Oxygen content in Venous blood

172

1.34

0.63

2.3

3.3

11.6

11.2

0.20

172

(3044242) Glucose [Moles/volume] in Arterial blood

112

1.43

0.63

1.5

2.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

100

1134

0.88

0.63

1.6

1.7

—

(1616796) Gas panel - Central venous blood

435

1.20

0.60

5.0

3.8

—

(3022689) Creatine [Moles/volume] in Urine

1.57

0.60

1.4

1.7

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

695

1.16

0.60

2.8

3.4

u/ml

46.3

5772.1

0.81

587

(46235168) Fasting glucose [Moles/volume] in Blood

0.00

0.59

0.0

1.6

—

7.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

516

4918

1.06

0.59

4.2

4.3

22.2

21.5

0.42

230

2372

(3024471) HLA-A [Type]

1.56

0.58

1.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

264

1.25

0.58

2.4

2.0

umol/l

6.4

5.2

0.18

186

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.72

0.57

7.3

3.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

466

1.18

0.57

1.8

1.6

—

(40768441) Liver Pathology biopsy report

151

1.33

0.54

1.5

1.4

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

108

1.39

0.53

1.3

1.4

—

73.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

305

1.22

0.51

1.1

u/ml

2.0

2.5

0.23

138

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

269

1.23

0.51

1.3

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

1.47

0.50

1.2

107.3

108.7

0.09

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.49

0.49

1.9

1.3

ug/l

10.1

9.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

110

1.37

0.48

1.2

1.1

—

11.8

—

(40768793) Breast Pathology biopsy report

456

1.17

0.48

1.3

—

(3044889) 12 lead EKG panel

1401

14265

0.96

0.47

3.8

3.7

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.46

0.46

2.3

3.1

—

(4024509)

182

1.27

0.46

1.3

1.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

120

1.34

0.46

3.4

2.0

—

(3004451) EKG impression Narrative

1.38

0.46

1.2

1.3

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.43

0.45

1.6

1.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.43

0.45

1.4

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

112

1018

1.10

0.45

1.6

1.4

iu/l

23.5

28.3

1.13

101

853

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

338

1.19

0.45

1.1

1.0

—

(40760892) CBC W Ordered Manual Differential panel - Blood

445

4637

0.95

0.43

5.8

4.4

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.61

0.43

1.0

1.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

230

1.22

0.42

2.3

2.4

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.56

0.42

1.0

1.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.56

0.42

2.8

2.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

131

1.30

0.42

1.0

u/ml

5.6

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.41

0.0

1.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

8.9

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

125

1151

1.09

0.40

1.3

1.4

—

(3032773) Endomysium IgG Ab [Titer] in Serum

195

1.23

0.40

1.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.47

0.40

1.2

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

347

0.83

0.40

1.2

u/ml

1.3

3.4

1.90

117

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

132

1.29

0.40

2.2

1.4

pmol/l

102.8

283.7

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.33

0.40

1.0

1.1

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

1.3

—

171.9

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.31

0.39

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.31

0.39

1.0

1.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

1.41

0.39

1.9

2.4

nmol/l

147.0

143.9

—

(3042517) Benzodiazepines panel - Urine

0.00

0.39

0.0

2.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

115

1.31

0.38

1.6

—

(3009871) Measles virus Ab [Titer] in Serum

1.36

0.38

1.9

1.7

—

(3023410) Appearance of Cerebral spinal fluid

215

1.21

0.38

1.8

1.9

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

819

1.10

0.38

1.7

mg/l

5.2

4.0

0.37

568

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

243

1.20

0.37

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.35

0.37

1.8

1.4

—

(3015183) Erythrocyte sedimentation rate

114

0.70

0.37

1.0

1.2

—

(3039000) Anion gap in Blood

440

1.14

0.36

5.4

9.2

mmol/l

11.6

11.3

0.24

387

(3018572) Chloride [Moles/volume] in Blood

441

1.14

0.36

5.4

9.1

mmol/l

105.4

105.3

0.07

388

(3045788) Cell count panel - Pleural fluid

171

1.23

0.35

1.9

1.4

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

0.63

0.35

3.0

2.6

e6/l

283.2

827.7

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.63

0.35

1.0

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

123

0.73

0.35

1.0

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

126

1.27

0.35

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

194

2054

0.94

0.35

3.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

218

1.19

0.34

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

377

1.14

0.34

2.8

3.2

nmol/l

0.7

0.8

0.99

294

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

127

1.26

0.33

2.2

2.9

42.0

40.6

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

759

1.10

0.33

1.6

mu/l

270.6

306.5

0.72

690

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

247

1.18

0.33

1.1

—

(3008295) Osmolality of Serum or Plasma

210

1.19

0.32

1.9

1.5

mosm/kgh2o

288.3

280.8

0.89

160

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

164

1.22

0.32

1.4

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

155

1.23

0.32

1.9

1.5

—

71.8

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

465

1.12

0.31

1.5

1.7

e6/l

2487.8

1189.6

0.27

380

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

465

1.12

0.31

1.4

1.6

e6/l

9.0

29.9

0.86

362

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

114

1062

1.08

0.31

3.0

3.3

u/ml

68.4

50.5

0.24

106

1024

(3035637) Corticotropin [Mass/volume] in Plasma

249

1.17

0.30

1.7

1.5

—

(21494434) Karyotype in Bone marrow

194

1.19

0.29

1.4

1.2

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

1.23

0.29

1.1

1.4

16.3

29.6

—

(3051611) Lipemic interference index of Serum or Plasma

195

1.18

0.28

4.1

3.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

158

1.20

0.28

1.0

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.29

0.28

1.9

2.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

116

0.78

0.27

1.2

1.6

—

(3025577) Chromium [Mass/volume] in Blood

120

0.75

0.27

2.8

2.1

ug/l

1.4

2.3

—

104

(1617658) Protocol used for examination of sentinel lymph nodes

172

0.81

0.27

1.0

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

131

1.22

0.27

1.0

ng/l

202.4

291.4

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

131

1.22

0.27

1.0

ng/l

849.3

694.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.21

0.26

1.0

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.21

0.26

3.9

2.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.21

0.26

1.0

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

215

1.16

0.26

9.5

6.7

mmol/l

7.5

7.4

0.05

179

(3025130) Human papilloma virus identified in Specimen

281

1.14

0.26

1.4

1.8

—

(40765096) Chromosome analysis panel by Banding

0.68

0.26

1.0

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

221

2119

1.05

0.25

1.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

160

1.19

0.25

1.3

1.6

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

160

1.19

0.25

1.2

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.22

0.25

1.0

—

(3006270) Folate [Moles/volume] in Blood

179

1.17

0.25

1.0

1.1

nmol/l

427.8

384.6

0.33

159

(3019060) Gas panel - Arterial blood

136

1289

1.06

0.24

4.1

5.5

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

133

1.20

0.24

1.0

ng/l

21.2

44.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

527

0.91

0.24

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

526

0.91

0.23

1.3

1.4

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

338

0.89

0.23

1.4

1.5

nmol/l

0.4

0.00

262

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

106

1.23

0.23

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.28

0.23

1.4

1.5

—

(3012565) Volume of 24 hour Urine

1.24

0.23

2.5

2.7

1935.8

2003.8

0.11

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

525

0.91

0.22

1.3

1.4

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.77

0.22

1.1

iu/ml

142.2

209.3

—

(3052592) Norovirus Ag [Presence] in Stool

1.25

0.22

1.0

1.5

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.22

0.22

3.0

3.2

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

1.22

0.22

1.2

2.6

mmol/l

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

524

0.91

0.22

1.3

1.4

—

(3051651) Icteric interference index of Serum or Plasma

116

1.21

0.22

4.0

3.8

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.21

0.0

4.2

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.21

0.0

1.3

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.1

—

7.9

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

0.00

0.21

0.0

1.3

—

43.4

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.21

0.0

1.1

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.1

—

7.8

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.1

—

21.1

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.1

—

37.4

—

(3042951) Complement C1q Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

26.9

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.1

—

(3029937) Albumin [Presence] in Urine by Test strip

531

5421

0.97

0.20

4.7

3.9

estimate

0.0

0.18

166

1836

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.25

0.20

1.3

1.0

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.20

0.0

1.0

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

278

1.12

0.20

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.25

0.20

1.0

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

572

0.92

0.19

1.3

1.5

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

404

1.09

0.19

3.5

e9/l

4.4

4.1

0.30

404

(4094501)

560

1.07

0.18

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

406

1.09

0.17

3.0

2.5

16.8

16.2

0.41

205

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.17

0.17

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

1.17

0.17

1.1

1.5

0.7

3.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.21

0.17

1.0

1.1

miu/ml

1901.2

1678.0

0.24

(44806420)

1.15

0.17

3.0

2.5

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

320

1.10

0.17

1.1

116.0

116.9

0.07

294

(3035933) Granulocytes/100 leukocytes in Blood

0.71

0.16

1.6

1.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

352

3442

1.03

0.16

1.4

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.16

0.16

1.1

1.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

762

7722

0.98

0.16

4.6

3.7

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

120

1.17

0.16

4.0

6.8

—

(40768800) Prostate Pathology biopsy report

379

1.08

0.16

1.1

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.13

0.16

1.0

1.5

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

130

0.85

0.16

1.0

1.1

u/l

1.0

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

214

0.89

0.15

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

458

1.07

0.15

3.3

3.5

mg/l

26.5

0.00

289

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

159

1.13

0.15

2.5

2.1

mg/l

6.5

4.7

0.34

152

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.08

0.14

3.0

4.4

—

(3017569) Oxygen content in Arterial blood

0.82

0.13

2.6

—

(3043409) Potassium [Moles/volume] in Arterial blood

599

1.05

0.12

3.1

4.1

mmol/l

3.9

0.06

553

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

104

1.15

0.12

1.5

1.8

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

104

1.15

0.12

1.5

1.8

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

336

1.07

0.12

1.3

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

162

1.11

0.11

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

557

5502

1.02

0.11

4.3

3.2

—

(4034850)

661

1.05

0.11

9.2

—

(3024263) Appearance of Synovial fluid

105

1.14

0.11

1.5

1.8

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

332

0.93

0.11

1.2

u/ml

4.2

5.2

0.16

139

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.14

0.10

1.0

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

349

1.06

0.10

1.4

1.6

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

420

1.05

0.08

4.1

3.7

57.9

57.5

0.08

420

(3003694) ABO and Rh group [Type] in Blood

597

5917

1.01

0.08

1.5

—

(3033799) Differential panel - Peritoneal fluid

0.78

0.08

2.8

2.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

117

1.11

0.08

1.1

u/ml

—

4.8

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

1.09

0.08

1.4

1.2

—

7.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

154

0.91

0.08

1.6

mmol/l

7.2

7.6

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

215

1.07

0.07

1.0

1.1

—

(3034426) Prothrombin time (PT)

1.07

0.07

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

334

1.05

0.06

1.1

—

(1002224) Polysomnography panel

871

0.98

0.06

1.0

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

780

0.97

0.06

1.8

1.9

—

(3039443) Prostate specific Ag panel - Serum or Plasma

364

0.96

0.05

1.3

1.7

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

140

0.93

0.04

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

665

0.98

0.04

1.4

—

(4027681)

129

0.93

0.03

1.3

1.2

—

(4306422)

330

1.03

0.03

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

108

0.93

0.03

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

321

1.03

0.02

1.7

1.3

—

(3014007) Fractional oxyhemoglobin in Arterial blood

125

1239

1.01

0.02

11.3

9.8

93.2

94.0

0.64

125

1231

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

113

1.06

0.01

2.1

2.4

84.6

97.6

1.05

107

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

164

1.04

0.00

1.2

2.3

u/field

7.7

1.9

—

(4281824)

224

1.03

0.00

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.05

0.00

2.1

1.9

—

(3017704) Immunofixation for Urine

121

0.99

0.00

1.3

1.8

—

(3012501) Base excess in Blood by calculation

451

1.00

0.00

4.9

4.4

mmol/l

2.0

2.6

0.96

305

(3005082) Progesterone [Moles/volume] in Serum or Plasma

104

0.96

0.00

1.7

1.4

nmol/l

33.8

31.7

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.02

0.00

1.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

112

0.98

0.00

1.9

1.5

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

182

0.99

0.00

1.5

28.8

30.9

0.08

115

(4268621)

228

1.01

0.00

2.1

2.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

338

1.01

0.00

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

277

1.01

0.00

1.4

1.3

mmol/l

8.0

7.3

0.28

204

(3045142) Bone marrow Pathology biopsy report

237

1.01

0.00

1.3

—

(40760409) HLA-A [Type] by High resolution

0.00

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.0

1.0

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.0

1.3

—

(3000012) Reticulocyte production index

0.96

0.00

1.2

1.6

—

(3022670) pH of Venous cord blood

0.00

0.0

1.0

—

(3007733) Chloride [Moles/volume] in Urine

0.00

0.0

1.7

—

66.0

—

(4133840)

0.94

0.00

1.0

1.2

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

2.4

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.0

14.6

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

1296.7

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

0.0

1.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.0

2.2

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

0.99

0.00

1.7

2.4

164.6

143.9

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.2

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

0.87

0.00

1.0

1.2

115.3

109.8

—

(3010421) pH of Blood

540

1.00

0.00

5.1

4.1

7.4

0.18

445

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

4.9

—

390.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.2

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.2

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.6

—

2923.3

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

5.8

—

0.2

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.90

0.00

2.5

1.9

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.0

5.6

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

0.0

3.6

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint H8_EXT_OTH and mortality.

Females

Parameter	HR [95% CI]	p-value
H8_EXT_OTH	1.082 [0.96, 1.22]	0.212
Birth year	0.997 [0.99, 1.01]	0.452

During the follow-up period (1.1.1998 — 31.12.2019), 895 out of 7630 females with H8_EXT_OTH died.

Males

Parameter	HR [95% CI]	p-value
H8_EXT_OTH	1.135 [1.01, 1.28]	0.035
Birth year	0.993 [0.98, 1.0]	0.119

During the follow-up period (1.1.1998 — 31.12.2019), 1100 out of 6157 males with H8_EXT_OTH died.

Mortality risk

Mortality risk for people of age

years, who have H8_EXT_OTH.

N-year risk	Females	Males
1	0.105%	0.268%
5	0.64%	1.405%
10	1.608%	3.864%
15	3.318%	7.644%
20	5.707%	12.63%

Relationships between endpoints

↥

Index endpoint: H8_EXT_OTH – Other otitis externa (chronic)

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other otitis externa (chronic)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints